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ABSTRACT OF DISSERTATION

AN OPTIMIZED SOLID-PHASE REDUCTION AND CAPTURE STRATEGY FOR
THE STUDY OF REVERSIBLY-OXIDIZED CYSTEINES AND ITS APPLICATION
TO METAL TOXICITY
The reversible oxidation of cysteine by reactive oxygen species (ROS) is both a
mechanism for cellular protein signaling as well as a cause of cellular injury and death
through the generation of oxidative stress. The study of cysteine oxidation is complicated
by the methodology currently available to isolate and enrich oxidized-cysteine containing
proteins. We sought to simplify this process by reducing the time needed to process
samples and reducing sample loss and contamination risk.
We accomplished this by eliminating precipitation steps needed for the protocol
by (a) introducing an in-solution NEM-quenching step prior to reduction and (b)
replacing soluble dithiothreitol reductant with a series of newly-developed high-capacity
polyacrylamide-based solid-phase reductants that could be easily separated from the
lysate through centrifugation. These modifications, collectively called resin-assisted
reduction and capture (RARC), reduced the time needed to perform the RAC method
from 2-3 days to 4-5 hours, while the overall quality and quantity of previously-oxidized
cysteines captured was increased.
In order to demonstrate the RARC method’s utility in studying complex cellular
oxidants, the optimized methodology was used to study cysteine oxidation caused by the
redox-active metals arsenic, cadmium, and chromium. As(III), Cr(VI), and Cd(II) were
all found to increase cysteine oxidation significantly, with As(III) and Cd(II) inducing
more oxidation than Cr(VI) following a 24-hour exposure to cytotoxic concentrations.
Label-free proteomic analysis and western blotting of RARC-isolated oxidized proteins
found a high degree of commonality between the proteins oxidized by these metals, with
cytoskeletal, translational, stress response, and metabolic proteins all being oxidized.
Several previously-unreported redox-active cysteines were also identified.
These results indicate that cysteine oxidation by As(III), Cr(VI), and Cd(II) may
play a significant role in these metals’ cytotoxicity and demonstrates the utility of the

RARC method as a strategy for studying reversible cysteine oxidation by oxidants in
oxidative signaling and disease. The RARC method is a simplification and improvement
upon the current state of the art which decreases the barrier of entry to studying cysteine
oxidation, allowing more researchers to study this modification. We predict that the
RARC methodology will be critical in expanding our understanding of reactive cysteines
in cellular function and disease.
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Chapter 1 : INTRODUCTION

Reactive oxygen and nitrogen species are both a natural byproduct of cellular
aerobic processes and toxic compounds that are implicit in cellular disease,
carcinogenesis, and aging. While the role of ROS and RNS in cellular signaling and
disease has been well-documented, there is still significant debate as to what the initial
targets for these species are upstream of any cellular signaling cascades. There has been
mounting evidence that protein thiols may be the link between ROS and RNS and cellular
signaling cascades.
However, the role of cysteines in ROS- and RNS-mediated signaling and disease
is still poorly understood. This is no accident, as cysteine oxidative status is difficult to
interrogate experimentally both in vitro and in vivo. Unlike phosphorylation, which is
relatively stable post-lysis barring phosphatase activity, the simple act of lysis can
introduce significant artefactual cysteine oxidation due to our oxidizing atmosphere.
Despite these hurdles, several techniques have been developed to study cysteine
oxidation. These techniques are for the most part cumbersome and tedious, typically
taking multiple days and requiring several precipitation and/or purification techniques.
By requiring so many steps and sample handling, the risk of sample loss, modification
loss, and contamination is greatly enhanced. Additionally the long workup time and
many steps involved relegates cysteine oxidation experiments towards the esoteric since
they require both a significant devotion of time as well as significant researcher
experience.
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With that in mind, it was our goal to streamline the experimental workflow to
address these issues, and then utilize these streamlined methods to study cysteine
oxidative modifications induced by environmental and occupational metal toxins. By
decreasing the amount of handling and precipitation steps, the overall ease in studying
cysteine oxidative modifications would be increased, pushing this post-translational
modification into the experimental mainstream.

Cysteine is one of the least common amino acids in the human proteome,
comprising only an estimated 1.7% of the amino acid composition. However the rate of
cysteine incorporated into the proteome has increased over evolutionary history,
coinciding both with a transition from a reducing to oxidizing environment as well as an
increase in organismal complexity [1, 2]. This increase in cysteine incorporation over the
course of evolution indicates the importance of cysteine for complex cellular functions.
Cellular cysteines play significant roles in protein structure and function. They provide
covalent inter- and intrachain linkages, act as catalytic centers for cellular enzymes, and
act as cellular antioxidants to prevent cellular oxidative damage.
There has been an increased interest recently in examining the role of cysteine in
cellular signaling networks. Since the sulfhydryl in cysteine can undergo reversible
redox in vivo, protein cysteines may act as cellular switches. Under oxidative stress a
switch cysteine would oxidize, altering protein structure or activity to induce a signaling
cascade; cellular antioxidants could then reduce the cysteine to “turn off” the signaling
cascade.
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Protein Thiol Oxidation
Characteristics of Cysteine
Cysteine, chemical formula C3H7NO2S, is a non-essential amino acid. Cysteine
and methionine are the two sulfur-containing amino acids in the human proteome, with
cysteine having a non-substituted thiol (-SH) in its side chain.
Sulfur has several characteristics that make it particularly useful. Due to its lower
electronegativity, it is a better nucleophile than oxygen. Sulfur’s electron configuration
of 1s2,2s2,2p6,3s2,3p4 allows for 8 oxidation states (+2,+1,-1,-2,-3,-4,-5,-6) compared to
oxygen’s four (2,1,-1,-2). This increase in oxidation states allows for a wider range of
reduction-oxidation reactions as well as an increase in binding partners for a sulfur
center.
The sulfur in cysteine is a thiol (RSH, S(II)) [3]. While is similar in most respects
to a hydroxyl group, thiols generally act as better nucleophiles under cellular conditions.
Therefore this allows for the cysteines to bind more, and more readily to, cellular targets.
Additionally, due to its decreased electronegativity it is easier to reduce the cysteine thiol
than a hydroxyl, such that cellular cysteines can readily undergo both oxidation and
reduction under cellular conditions.
While other amino acids can be oxidized in vivo, only the two sulfur-containing
amino acids cysteine and methionine are readily reduced. In the case of cysteine, this
reversibility allows for cysteine to be act as a redox center for enzymatic catalysis, a
target for cellular oxidants, and a malleable component of protein structure.
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The propensity for the cysteine thiol to be oxidized is dependent upon pH.
Cysteine is oxidized only in its thiolate state. As discussed below, the thiol pKa is ~8.5;
therefore at physiological conditions cysteine would exist primarily as a protonated thiol
and be incapable of undergoing redox. How, then, can cysteine exist as a thiolate under
physiological conditions?
The influence of nearby groups on thiol pKa has been clearly demonstrated
through multiple studies, as summarized in Table 1.1. The presence of positivelycharged groups in close proximity to the thiol will reduce the pKa, while the presence of
negatively-charged groups will generally increase the pKa. As seen in Table 1.1, the
substitution of an alcohol group in β-mercaptoethanol to an amine group in βmercaptoethylamine decreases the thiol pKa from 9.72 to 8.35. Thiol pKa increases as
the distance between the thiol and an amine increases, as seen in the series from 2diethylaminoethanethiol to 2-diethylaminohexanethiol [4].
Cysteine contains three dissociable protons (those of the carboxylic acid, thiol,
and ammonium), which would give three separate pKas. While the pKa of the carboxyl
group can be clearly identified, the pKas of the thiol and ammonium groups overlap and,
as mentioned above, affect each other greatly. Therefore determining the pKa of the
cysteine side chain thiol has been the subject of many studies. Through using
spectrophotometric measurements Benesch and Benesch measured the cysteine thiol pKa
as 8.53 [5]. Thurlkill et al. used potentiometric titration on peptide hexamers consisting
of Ala-Ala-Cys-Ala-Ala-Ala to arrive at a thiol pKa of 8.55 [6].
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Table 1.1. The experimentally-determined pKSH of simple and physiological thiolcontaining compounds.
Chemical Name
Ethanethiol
β-mercaptoethanol
β-mercaptoethylamine
2-diethylaminoethanethiol
2-diethylaminopropanethiol
2-diethylaminobutanethiol
2-diethylaminohexanethiol
l-cysteine
Glutathione

Chemical Formula
C2H5-SH
HO-C2H4-SH
H2N-C2H4-SH
(C2H5)2-N-C2H4SH
(C2H5)2-N-C3H6SH
(C2H5)2-N-C4H8SH
(C2H5)2-N-C6H12SH
HO2CCH(NH2)-CH2SH
Glu-Cys-Gly

pKSH
10.61
9.72
8.35
7.8
8.0
10.10
10.10
8.53
9.20

Reference

[4]
[4]
[4]
[4]
[5]

The influence of neighboring charged groups on cysteine thiol pKa means that
protein cysteines may have measurable pKas that are far different than that of free
cysteine. Positively charged groups from adjacent or proximate amino acids such as
arginine, histidine, and lysine could significantly shift the thiol pKa; furthermore the
burying of cysteines within a protein may lead to a dehydration of the area surrounding
the thiol, leading to a far different dielectric constant. These different variables allow for
large variability in reported protein cysteine values, ranging from 2.5 – 11.1, with a mean
protein cysteine pKa of 6.8 ± 2.7 [7].
At a physiological pH of 7.4, free cysteine will be primarily in the protonated
thiol (-SH) state; however a significant portion of cysteines will be in an unprotonated
thiolate (-S-) state due both to the pKSH as well as conformationally-induced pK shifts.
This is in sharp contrast to the cellular antioxidant tripeptide glutathione, which has a
pKa of 9.2. As thiolates are nucleophilic and readily undergo redox reactions, cysteines
will be oxidized more readily and at a faster rate than glutathione under physiological
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conditions [8]. Glutathione is present intracellular at millimolar concentrations, making
it the predominant cellular thiol and a significant cellular antioxidant [9]. However the
greater reactivity of cysteines towards oxidants, coupled with the critical roles that
cysteines play in protein structure and activity means that cysteine oxidation could act as
an early sensor of oxidative stress, affecting protein structure and function and mediating
downstream signaling.
Therefore it is important to understand the different forms of oxidized cysteine
that may be encountered in the cell, as well as their characteristics. Cysteine oxidation
products can generally be categorized as reversible or irreversible, based upon the ease
with which the oxidation product can be reduced back to a thiol under physiological
conditions.
Cysteine Modifications by Radical Species
Oxidative Modifications
Cysteine oxidative products are those that are generated by the radical attack of
reactive oxygen species (ROS) on cysteine thiols. These oxidative products have been
classically organized into two groups: reversible and irreversible. The reversible
oxidative products are those that were perceived to be easily reversed under physiological
conditions through a reduction-oxidation reaction by cellular antioxidants, such as
glutathione, and antioxidant proteins, such as thioredoxin and peroxiredoxin. The
irreversible oxidative products were perceived to be biologically irreversible, although it
is now understood that some modifications that were considered to be irreversible are in
fact reversible in vivo under certain conditions [10, 11].
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Irreversible cysteine oxidation. Irreversible cysteine oxidation to a sulfinic acid (-SO2H)
or sulfonic acid (-SO3H) may result in inactivation of protein function. For instance,
hyperoxidation of the active-site cysteine of GAPDH to a sulfinic acid leads to an
irreversible inactivation of enzymatic function [12, 13]. Likewise oxidant-mediated
active-site selenocysteine hyperoxidation of glutathione peroxidase 1 (GPX) [14, 15] and
active-site cysteine hyperoxidation of superoxide dismutase 1 (SOD1) and catalase [16]
cause irreversible inactivation of key cellular antioxidant enzymes. While sulfiredoxin is
capable of reducing cysteine sulfinic acids to thiols, its substrate specificity of 2-Cys
peroxiredoxins [10] means that cysteine and selenocysteine hyperoxidation of these
enzymes is physiologically irreversible.
However not all hyperoxidized proteins are necessarily inactivated by cysteine
sulfinic and sulfonic acids. An excellent example of hyperoxidation-mediated protein
function is the cellular redox sensor DJ-1/PARK7. DJ-1/PARK7 is a multifunctional
protein which contains three cysteines: Cys46, Cys53, and Cys106. Under oxidative
stress Cys106 is irreversibly hyperoxidized to a sulfinic acid, leading to conformational
changes and causing subcellular redistribution to the mitochondria [17] and nucleus.
Hyperoxidized DJ-1/PARK7 acts as a pro-survival agent within cells undergoing
oxidative stress, inhibiting apoptosis signaling kinase 1 activation by preventing ASK1Daxx interaction [18] and Trx1-ASK1 complex dissolution [19]. Hyperoxidized DJ1/PARK7 also inhibits apoptotic MEKK1-SEK1-JNK1 signaling [20], inhibits PTEN
dephosphorylation of Akt/PKB [21], sequesters p53 from transcriptional activation [22],
and increases antiapoptotic ERK1/2 signaling [22]. These activities, all triggered by DJ-
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1/PARK7 C106 sulfinylation, delay cellular apoptosis under oxidative stress to allow
time for antioxidant recovery.
Reversible cysteine oxidation and sulfenic acids. Reversible oxidative modifications
include sulfenic acids (-SOH), disulfides (-SS-), and nitrosothiols (-SNO). Sulfenic acids
are considered to be unstable intermediate oxidative products and generally will rapidly
oxidize further to disulfides [23], sulfenamides [24], or sulfinic and sulfonic acids; this is
due to the abstraction of oxygen by the electronegative oxygen to give a highly
electrophilic sulfur which can undergo further nucleophilic attack.
However some proteins have been demonstrated to form stable sulfenic acids
through conformational restriction of further oxidation [25]. Oxidoreductase enzymes,
such as NADH peroxidase and NADH oxidase, utilize a stabilized sulfenic acid in their
catalytic centers. Additionally stabilized sulfenic acids have been shown to form a rapid
redox switch for cell signaling in transcription factors, antioxidant proteins, and cell
survival and apoptotic proteins (reviewed in [26]).
Sulfenic acids play a significant role in cellular response to oxidative stress. The
active-site cysteine Cys152 in glyceraldehyde-3-phosphate dehydrogenase is reversiblyoxidized to a sulfenic acid when exposed to nitric oxide generators such as sodium
nitroprusside [27], leading to an inhibition of glycolysis and redirection of
glyceraldehyde-3-phosphate towards the pentose phosphate pathway to generate NADPH
for antioxidant response [28]. Cysteine sulfenic acid oxidation on the antiapoptotic
protein Bcl-2 by hydrogen peroxide prevents its interaction with and suppression of
apoptotic ERK1/2 signaling [29].
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Disulfides. A disulfide is a thioether formed either between two cysteines (Cys-S-S-Cys)
in the case of a cysteine disulfides, or between a cysteine and a non-cysteine thiol species
(ex. Cys-S-S-Glutathione) in the case of mixed disulfides. Cysteine disulfides are a
crucial structural element of proteins, contributing to secondary, tertiary, and quaternary
structure [30]. Disulfides are a key non-primary structural motif due to the energetic
favorability of disulfide formation. Under oxidizing physiological conditions cysteines
will readily undergo oxidation to form disulfides [31], although disulfide formation is in
vivo is catalyzed and error-corrected in the endoplasmic reticulum by the oxidorectase
protein disulfide isomerases [32, 33].
While protein cysteines will form disulfides spontaneously, incorrect and
disulfide formation can cause severe perturbations to protein structure and cell function.
Protein disulfide misfolding caused by protein disulfide isomerase disruption results in
ER stress and has been linked to apoptosis [34], neurodegeneration [35], and diabetes
[36].
In addition to structural elements and protein folding, disulfides have been shown
to act as redox sensors. Cysteine-cysteine disulfides and mixed glutathione-cysteine
disulfides regulate Nrf2 stabilization ([37]), phosphatase and kinase activity, proteosomal
function, and apoptosis (reviewed in [38]). Beyond their role in unfolded protein
response, PDIs have been proposed to be key oxidative stress regulatory hubs through
disulfide formation, driving a variety of signaling cascades [39].
Nitrosothiols. Reactive nitrogen species such as nitric oxide can induce the formation of
cysteine-S-nitrosothiols (Cys-SNO). Nitric oxide is generated endogenously by the
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constitutively-expressed family of nitric oxide synthases (NOSs), including eNOS, iNOS,
and nNOS.
As with the other reversible oxidative products discussed previously, Snitrosylation of cysteines has been shown to regulate protein cell signaling cascades.
Cardiovascular regulation of vasodilation by nitric oxide is driven by S-nitrosylation [40].
Nitric oxide has also been linked to inflammation [41], UPR signaling, diabetes [42],
neurodegeneration [43], antiapoptotic signaling [44], autophagic resistance [45], and
inhibition of cellular kinases [42].
Methods for Detecting Cysteine Oxidation
Given the widespread impact of cysteine oxidative adducts on both homeostasis
and cellular pathology, the presence of cysteine oxidative modifications and their
contribution to protein structure and function has been a topic of research for the past
century. While early studies focused on the relationship between cysteine and cysteine,
as well as cysteine’s role in urinary calculi, by the 1960s researchers had identified that
cysteine played a significant role in protein stability and structure.
Early studies into cysteine oxidation states relied upon several methods. These methods
included X-ray crystallography [46], amino acid analysis, nonreducing/reducing diagonal
gel electrophoresis [47], and protein mass-shifts induced by cysteine alkylation by highmolecular weight alkylating reagents [48]. While these methods used different
approaches and arrived at different endpoints for their analyses, they were collectively
slow, laborious, and were inefficient as methods to discover previously unidentified
reversibly-oxidized cysteines.
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In 2001 Jaffrey et al. first described the basic framework of the biotin-switch assay
(BSA) [49]. The BSA used ascorbate to reduce nitrosothiols, leaving all other oxidative
cellular modifications unperturbed. In the BSA cellular thiols are blocked using the
methyl methanethiosulfonate (MMTS), after which excess MMTS is removed,
nitrosothiols are reduced with ascorbate, and the newly-reduced thiols are biotinylated
using biotin-HPDP.
The development of the biotin-switch assay was a significant advancement in the field of
cysteine redox signaling. Since the endpoint for the BSA was biotinylation of
nitrosothiols, it allowed the enrichment and study of the nitrosothiol-containing fraction
of the proteome. The BSA was not without its drawbacks, however. Ascorbate has been
shown to be capable of reducing some cellular disulfides, reducing the overall specificity
of the BSA [50, 51]; furthermore the biotinylation endpoint adds undue complexity to the
assay since it requires the removal of excess biotinylation prior to streptavidin pulldown.
In the decades following the first description of the BSA, researchers have
developed modifications and improvements of the BSA to alleviate these issues and
broaden its applicability. Leichert and Jakob introduced a disulfide quench step
consisting of direct lysis of samples in 10% trichloroacetic acid (TCA) prior to alkylation.
The rapid decrease in pH and protein denaturation caused by the TCA was presumed to
eliminate disulfide exchange, freezing the cellular thiol status [52]. The alkylation
reagent used has changed from the haloalkanes iodoacetate (IAA) and iodoacetamide
(IAM) to N-ethylmaleimide (NEM), which has the advantage of faster cysteine alkylation
at neutral and slightly acidic pH (pH 6.5-7.5). Reduction methods were expanded to
probe for all manner of cysteine oxidation products, including protein disulfides. Finally,
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the most fundamental change in the BSA technique has been the transition away from
biotin itself towards resin-assisted capture (RAC).
In RAC the biotin-streptavidin capture is replaced by substituting an activateddisulfide thiopyridine resin [53]. Following alkylation and reduction, the newly-reduced
cysteines are bound covalently to the solid-phase resin through mixed disulfide bonds.
The benefits of RAC are threefold. Using RAC instead of biotin-streptavidin pulldown
eliminates the need to remove any excess biotin from the sample. Furthermore, since the
capture is through a covalent bond the reaction can occur under highly denaturing
conditions, and more stringent wash conditions can be used to eliminate any non-specific
interactions. Finally, since the cysteine is bound to the resin through a disulfide bond the
protein can be gently eluted by the addition of a reducing agent.
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Figure 1.1. The resin-assisted capture (RAC) methodology. Cells are lysed in the
presence of cysteine alkylating reagents such as N-ethylmaleimide (NEM), which
alkylate reduced cysteine thiols, blocking them from being captured by activated thiol
resins. Reversibly-oxidized cysteines, including cysteine s-nitrosothiols and disulfides,
are then reduced by reducing agents. The newly-reduced cysteines then form mixed
disulfides with an activated thiol resin, which allows the proteins containing previouslyoxidized cysteines to be captured and separated from non-oxidized proteins. Captured
proteins can be eluted from the resin with the simple addition of a cysteine reductant such
as dithiothreitol (DTT) or tris(carboxylethy)phosphine (TCEP).
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As a technique, RAC is dependent upon the reductant used to determine what
kind of cysteine oxidative adducts it captures (Fig. 1). The use of ascorbic or sinapinic
[54, 55] acids will result in the reduction and capture of S-nitrosothiols, while using
sodium arsenite will lead to the reduction and capture of sulfenic acids. The use of a
nonspecific thiol reductant like dithiothreitol (DTT) will reduce and capture all reversible
cysteine oxidative adducts present.
Unfortunately using RAC for studying total protein oxidation comes with
significant drawbacks. Since the reduction of nitrosothiols and sulfenic acids is specific
for those species, reduction and capture can occur at the same time. However since the
dithiopyridyl capture resin is based on an activated disulfide, any attempt to reduce
cellular disulfides at the same time as capture would result in at best the immediate
cleavage of any newly-formed mixed disulfides, and at worst would neutralize the
capturing resin entirely. Therefore total protein oxidation studies require a two-step
reduction and capture, wherein the proteins are reduced with DTT, after which the excess
reductant must be removed by precipitation, ultrafiltration, or dialysis prior to capture.
The necessary removal of the reductant prior to capture limits the throughput of the RAC
when it comes to studying total protein oxidation. As it stands this method requires, from
start to finish, at least two days to finish using chloroform-methanol precipitation; using
the more quantitative acetone precipitation would require at least three days to prepare a
sample for capture and analysis. Additionally each step requires significant user
manipulation, risking sample contamination and/or loss.
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Tangible improvements have been made in streamlining methodology for
nitrosothiol RAC through thiosulfonate switching [56, 57]. However very little
advancement has been done on its sister technique in this regard. An alternative approach
to total protein oxidation RAC was developed by the Cross group [58] which eliminated
the precipitation step between alkylation and reduction in order to reduce the time needed
to perform the RAC technique. However this method has not been adopted by the wider
community, nor has it been compared to the classical RAC method in order to determine
whether its modifications have conferred tangible improvements to the technique beyond
processing time reduction.
We therefore saw an opportunity to reevaluate total protein oxidation RAC and
improve upon it. Using the iterative improvements to date as a starting point, our goal
was to reduce the time needed to process samples with the RAC technique to one that
could be performed in a single workday, with a reduced need for precipitation and
handling. It was intended that optimization of the RAC technique would allow for lower
sample variability and error, higher throughput, increased ease of use, and the potential of
automation. These benefits would decrease the barrier to entry for researchers interested
in using RAC to study cysteine oxidation, increasing the body of knowledge surrounding
cysteine oxidative signaling and redox modifications.
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Chapter 2 : OPTIMIZATION OF INCUBATION CONDITIONS FOR RESINASSISTED CAPTURE OF TOTAL OXIDIZED CYSTEINES.

Background
There are two distinct workflows used for resin-assisted capture of reversiblyoxidized cysteines: the Purification of Reversibly-Oxidized Proteins (PROP) method [58]
and the Oxidized Resin-Assisted Capture (Ox-RAC) method [59, 60]. Both of these
techniques follow the same basic structure, alkylation-reduction-capture, but they differ
in a few key respects. The Ox-RAC technique adheres closely to the BSA workflow; it
uses an SDS-based lysis buffer, either NEM or IAM as an alkylating reagent, and most
importantly uses a two-step alkylation/reduction where the alkylating reagent is first
removed from the lysate by organic precipitation and washing, then the lysate is
resuspended in reducing buffer.
The PROP technique differs from the Ox-RAC technique in that it uses a
guanidine-based lysis buffer, specifically identifies NEM as the preferred alkylating
reagent, and uses a one-step alkylation/reduction buffer where following alkylation an
overwhelming amount of DTT is added to the lysate to both quench the NEM and reduce
cysteines. The benefit of the PROP workflow is that by removing one precipitation/wash
step, sample loss is reduced and the procedure is shortened by one day.
Given the variations between the two methods, it was important that these
differences were compared to determine the optimal conditions for analysis. Additionally
it highlighted several areas in which the Ox-RAC method could be improved upon to
decrease handling steps, sample loss, and method time. While these improvements
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would naturally make the method shorter, it would also reduce or eliminate the use of
hazardous organic solvents, decrease sample variability, and make the method more userfriendly.
Therefore we identified the key differences between the two methods and
compared them. These variables included the inclusion of an acid-quenching step, the
denaturant and alkylating reagent used, and using either a one- or two-step
alkylation/reduction. We then altered the method further by using solid-phase reducing
resins to eliminate the need for precipitation and buffer exchange.

Materials and Methods
Materials. The immortalized human bronchial epithelial cell line BEAS-2B was
purchased from American Type Culture Collection (ATCC CRL-9609). Cell culture
medium (Gibco DMEM+GlutaMAX, Gibco 10569), HBSS pH 7.4 (Gibco 14025), PBS
pH 7.4 (Gibco 10010), trichloroacetic acid (Fisher BP555, Lot# 165234), 5,5’-dithiobis(2-nitrobenzoic acid) (Thermo Scientific 22582, Lot# OG189149A), and screw cap
microcentrifuge spin columns (Pierce 69705) were purchased from Thermo Fisher
Scientific (Waltham, MA). Sepharose 6B (Aldrich 6B100, Lot# MKCG3369), sodium
borohydride (Aldrich 452882 Lot# SHBF1327V), ethyl 3-benzoylacrylate (Aldrich
260614, Lot# STDB7349V), ethyl vinyl sulfone (Aldrich 282839, Lot# MKCB3364V),
phenyl vinyl sulfone (Aldrich 241717, Lot# 0001451652), methyl propiolate (Aldrich
171859, Lot# BCBT5514), ethyl propiolate (Aldrich E46607, Lot# STBG4123V), 3phenyl 2-propynenitrile (Aldrich 672645), methyl sulfonylbenzothiazole (Enamine
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ENA069848532), and 1-(2-aminoethyl)maleimide (Aldrich 809322) were purchased
from Millipore Sigma (St. Louis, MO). Epichlorohydrin (Alfa Aesar A15823, Lot#
Y13B038), sodium thiosulfate (Alfa Aesar A17629 Lot# 10205369), N-ethylmaleimide
(Alfa Aesar 40526, Lot#P290042), acrylamide (Alfa Aesar J62100 Lot# P17C510),
methyl acrylate (TCI FII01-RPGO), iodoacetamide (Amresco M216 Lot# 1835C142), 2mercaptoethylamine hydrochloride (Alfa Aesar A14377, Lot# 10173644), dithiothreitol
(VWR 97061), and all other ancillary materials and consumables were purchased from
VWR (Radnor, PA).
Cell Culture. The human bronchial epithelial cell line BEAS-2B was grown at 37° C in a
humidified incubator with a 5% CO2 atmosphere in DMEM+GlutaMAX, 10% FBS, 1%
penicillin-streptomycin. BEAS-2B was subcultured prior to confluence and plated at a
density of 3,000-5,000 cells/cm2. Following plating, the cells were grown to ~65-80%
confluence for treatment, and only passages 60-90 were used for experiments.
Synthesis of Epoxide Resins
Epoxide Resin. Epoxide resin was synthesized as described by Axen et al. [61] using the
modifications provided by Matsumoto et al. [62] Sepharose or sephadex resin was
washed free from its storage buffer using deionized water under vacuum on a fritted glass
filter, then allowed to dry under vacuum until no more water passed through the filter. 2g
of the washed resin was added to 3 ml of 56% DMSO in deionized water, to which 1.3 ml
of 2M sodium hydroxide and 0.3 ml of epichlorohydrin were added in order. The
suspension was incubated at 40°C for 2 hours with mixing, after which the resin was
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washed with 50 ml of deionized water. The epoxide resin was not stable enough to store
long-term, so subsequent reactions were conducted immediately.
S-Alkyl-Thiosulfate Resin. 2g of epoxide resin was washed with 0.5M sodium phosphate
buffer, pH 6.3. It was then resuspended in 4 ml of the same buffer, to which 2 ml of 2M
sodium thiosulfate was added. The suspension was incubated for 6 hours at RT with endover-end mixing. The resin was then washed with deionized water and resuspended in
phosphate buffered saline. The resin was stored at 4° C in 20% ethanol/PBS.
Thiol Resin. 2g of S-alkyl-thiosulfate resin was washed with deionized water followed
by methanol and allowed to dry on a fritted glass filter. The resin was then resuspended
in 10 ml of methanol in a peptide synthesis vessel. 700 mg of sodium borohydride (20
mmol) was added to the suspension, and nitrogen was bubbled through the vessel. The
suspension was incubated for 1 hour at RT. The resin was then dried under vacuum and
washed with 50 ml of 0.1M acetic acid to neutralize any remaining borohydride. The
resin was stored short-term in 0.1M acetic acid at 4° C.
Thiopropyl Resin. 2g of thiol resin was washed with 60% acetone/40% 0.05M sodium
bicarbonate/1 mM EDTA. It was then resuspended in 5 ml of the same solvent, to which
0.3M of 2,2'-dipyridyl disulfide in the same solvent was added. The suspension was
incubated for 1 hour at RT in the dark with end-over-end mixing. The resin was washed
with 60% acetone, followed by 1 mM EDTA in water. The resin was stored in 20%
ethanol/PBS in the dark at 4° C or lyophilized [63] for long-term storage.
Cell Lysis. BEAS-2B cells were plated onto 10-cm2 dishes and grown to 65-80%
confluence. Upon reaching the desired % confluency the cell culture medium was
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replaced with culture medium containing treatment compounds or vehicle alone.
Following treatment exposure the plates were washed 3x with HBSS, the cells were
detached from the plate with a cell lifter, collected into 1.5ml tubes, pelleted, and lysed in
400 μl of degassed lysis buffer (20 mM NaHPO4, 1 mM EDTA, 0.1% IGEPAL CA-630,
2% SDS unless otherwise noted). Lysate DNA was sheared by sonicating the samples
using 10 30-second cycles in a BioRuptor Pico (Diagenode, Denville, NJ). The
supernatant was transferred to a clean tube and either used immediately in downstream
assays or flash frozen and stored at -80°C.
Thiol Measurement. Sample thiol content was measured using the 5,5’-dithiobis-(2nitrobenzoi acid) (DTNB) assay [64, 65]. Thiol-containing samples were solubilized in
DTNB assay buffer (100 mM Tris, pH 7.8, 1 mM EDTA), then mixed with DTNB assay
buffer containing 10 mM DTNB; for 96-well plates the volume ratio of sample:DTNB
was 1:2. The samples were mixed thoroughly and allowed to incubate at RT in the dark
for 10 minutes, after which sample absorbance was measured at λ=405 nm on a BioTek
EL800 spectrophotometer (BioTek Instruments, Winooski, VT). An internal set of thiol
standards consisting of known concentrations of mercaptoethylamine was included in
each run to verify accuracy of the measurements.
Trichloroacetic Acid Disulfide Quenching. Pelleted BEAS-2B cells were thoroughly
resuspended in 1 ml of 4% trichloroacetic acid (TCA) by pipetting and incubated for 10
minutes at room temperature. Following incubation the proteins were pelleted by
centrifugation at 16,000g for 5 minutes. The pellet was washed 1x in 4% TCA, then 3x
in cold methanol; the pellet was thoroughly resuspended for each wash by pipetting.
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Following the final wash the pellet was allowed to dry briefly to remove residual
methanol, then the pellet was resuspended in degassed lysis buffer.
Prelysis Quenching. Following treatment the cell culture medium was exchanged with
HBSS containing NEM (50 mM unless otherwise noted) and incubated briefly. After
incubation the HBSS + NEM was removed, the plates were washed 3x with HBSS, the
cells were detached from the plate with a cell lifter, collected into 1.5ml tubes, pelleted,
and resuspended in degassed lysis buffer.
Lysate Alkylation and Reduction. BEAS-2B cells were lysed in 400 μl of degassed lysis
buffer containing 20 mM NEM in opaque 2-ml microcentrifuge tubes. The samples were
incubated for 2 hours at RT with gentle end-over-end mixing. The samples were then
precipitated by the addition of 4 volumes (1.6 ml) of prechilled acetone, vortexed, and
precipitated overnight at -20°C. The precipitated protein was collected by centrifugation
at 4,000g for 5 minutes in a 4° C microcentrifuge. The supernatant was removed and the
protein pellet was washed 3x with cold 80% acetone. The samples were then allowed to
dry briefly to remove excess acetone, then resuspended by pipetting in 400 μl of lysis
buffer containing 50 mM DTT. After a one-hour incubation the samples were again
precipitated with cold acetone, allowed to incubate overnight at -20°C, and washed 3x
with cold 80% acetone before resuspension for RAC.
Resin-Assisted Capture. Alkylated and reduced sample pellets were resuspended by
pipetting in 400 μl of capture buffer (20 mM CH3COONa pH 4.5, 2% SDS, 1 mM
EDTA). Sample concentration was measured by BCA assay [66], and equal
concentrations of lysates were added to microcentrifuge spin columns containing 35 mg
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of buffer-equilibrated thipropyl resin. The columns were sealed and the slurry was
incubated for one hour at RT with rotation. Following incubation the columns were
unsealed, placed into waste collection tubes, and centrifuged at 1,000g for 1 minute to
remove all nonbound proteins. The columns were washed with 5 column volumes of
capture buffer, 5 column volumes of diH2O, and 1 column volume of Laemmli sample
buffer. After the final wash 100 μl of Lammli buffer containing 50 mM DTT was added
to the columns, which were sealed and rotated at RT for 30 minutes. The columns were
then unsealed, placed in clean 1.5 ml microcentrifuge tubes, and centrifuged at 1,000g to
collect the bound fraction.
Gel Electrophoresis and Staining. Equal volumes of sample bound fractions were loaded
in adjacent wells of NuPAGE Bis-Tris gels. Equal concentrations of input fractions were
loaded to verify equivalent loading of the spin columns between samples. Gels were run
in MOPS SDS-PAGE running buffer at 200V. Following electrophoresis the gels were
removed from the gel cassettes, cut, and placed directly into fixation solution (10% acetic
acid, 50% methanol) and incubated with RT for 15 minutes at RT. The fixation solution
was decanted and replaced with staining solution (0.025% Coomassie G-250, 10% acetic
acid), and the samples were incubated with rocking for 30 minutes at RT. The staining
solution was decanted and the gels were destained with two 30-minute incubations in
10% acetic acid. Following destain the gels were imaged using a ChemiDoc XRS (BioRad, Hercules, CA).
Results and Discussion
Use of Trichloroacetic Acid for Disulfide Quenching
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The use of trichloroacetic acid (TCA) as an acid-quench step was first proposed
by Leichert and Jakob [52]. By adding a denaturing amount of TCA to intact cells the
cells would be lysed, proteins would be denatured, and the free cysteine thiols would be
protonated; this would prevent disulfide exchange and giving a cellular “snapshot” of
cysteine oxidation status. Therefore TCA quenching has become an integral step in the
BSA technique [60].
However the use of TCA quenching has been called into question. Curbo et al.
found that diamide, a potent thiol oxidant, was still able to oxidize protein thiols during
TCA quenching [67]. Since cysteine oxidation post-lysis during the quench step would
be stochastic, this would increase non-specific oxidative “noise” in subsequent steps of
the assay.
An additional concern regarding the use of TCA quenching which was of great
concern to our research field was the possibility of generating more-reactive metal
species during the acid quench. It is well-known that some transition metals, such as
chromate, are highly oxidative at low pH. There was a concern that these metals could
induce post-lysis oxidation of the samples during TCA quench. We therefore wanted to
determine whether acid-quenching in the presence of redox-active metals could cause
post-lysis oxidation in a manner similar to that of diamide.
BEAS-2B pellets were lysed in 4% TCA [68] either alone or in the presence of
metals (As(III), Cd(II), or Cr(VI)) at concentrations commonly used for in vitro
experiments for 10 minutes to demonstrate whether these metals were capable of
inducing protein cysteine oxidation over a short exposure period at low pH. Fig. 2.1
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shows the results of this experiment. While arsenic caused no discernable increase in
cysteine oxidation relative to the control, both cadmium and chromium caused post-lysis
oxidation with Cr(VI)-induced oxidation being much higher than Cd(II)-induced
oxidation (Fig. 2.1A). Cr(VI) is known to be a highly oxidizing agent at low pH, so postlysis metal-induced oxidation was not unexpected.

Figure 2.1. TCA disulfide quenching causes postlysis oxidation by reactive metals.
BEAS-2B cells were quenched by the addition of trichloroacetic acid (TCA) to starvation
medium (DMEM) to a final concentration of 4% TCA. During quenching the cells
remained untreated or were treated with NaAsO2, K2Cr2O7, or CdCl2 in the acidified
medium for 10 minutes. Following quench in the presence acidified metals, cells were
collected, washed, and processed for resin-assisted capture (RAC) analysis as described
in the Methods. Input fractions are 5 μg of total lysate for each sample. Pulldown
fractions are equivalent volumes of resin-assisted capture eluate representing reversiblyoxidized proteins for each sample. (A) BEAS-2B cells were treated with 5-10 μM of
As3+, Cr6+ or Cd2+ for 10 minute in the presence of 4% TCA. Equivalent amounts of
RAC-processed whole cell lysates as determined by bicinchoninic acid assay were loaded
onto thiopropyl-sepharose columns to capture oxidized proteins, washed, and eluted
(RAC pulldown). The lanes on the left side of the figure were loaded with 5 μg of RACprocessed whole cell lysate (INPUT), and the lanes on the right side of the figure were
loaded with 20 μl of eluate (PULLDOWN) containing only oxidized proteins from each
treatment. (B) BEAS-2B cells were pretreated with 20 mM N-ethylmaleimide (NEM)
(lanes 3-5, 8-10) prior to TCA quenching and treatment with diH2O vehicle (Lanes 1, 3,
6, 8) or 10 μM Cr(VI) (Lanes 2, 4, 7, 9) for 10 minutes as in part A. Lanes 5 and 10 are
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from BEAS-2B cells which were pretreated with NEM but not acid-quenched.
Equivalent amounts of RAC-processed whole cell lysates were loaded into thiopropylsepharose columns to capture oxidized proteins, washed, and eluted. The lanes on the
left side of the figure were loaded with 5 μg of RAC-processed whole cell lysate
(INPUT), and the lanes on the right side of the figure were loaded with 20 μl of eluate
(PULLDOWN) containing only oxidized proteins from each treatment. The gels were
visualized after electrophoresis using Coomassie G-250.

Cysteine oxidation by chromic acid during the TCA quench would only occur in
the presence of free, reduced cysteines. We wanted therefore to see whether alkylating
free thiols prior to lysis and quench, thereby eliminating the pool of free thiols available
for oxidation, would be an effective way to avoid chromic acid post-lysis oxidation. We
pretreated BEAS-2B cells with 20 mM N-ethylmaleimide prior to TCA quenching alone
or in the presence of Cr(VI) (Fig. 2.1B). Pre-lysis treatment with NEM significantly
decreased post-lysis cysteine oxidation by chromic acid, reducing it to nearly that of
control.
Pre-Lysis Disulfide Quenching with N-Ethylmaleimide
TCA quenching was originally conceived of as a way to prevent cysteine
oxidation and disulfide exchange by the rapid denaturation of proteins in a low-pH
solution. Unfortunately as we have shown above, the presence of certain metals in the
TCA solution, whether due to metal treatment or as trace contaminants, can induce postlysis oxidation upon acidification; this effect was greatly reduced by the pretreatment of
cells with NEM prior to TCA quenching, since the membrane-permeable NEM would
alkylate accessible cysteines in vitro prior to lysis, thereby greatly reducing the
population of free thiols at risk of post-lysis oxidation.
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In addition to using NEM prior to TCA quenching, we also tested NEM treatment
without TCA quenching (Fig. 2.1B, Lanes 5 and 10). We found that NEM prelysis
treatment reduced post-lysis cysteine oxidation to levels comparable to that obtained by
TCA quenching (Fig. 2.1B, Lanes 1 and 6). Due to this we reasoned that NEM prelysis
quenching of accessible cysteines could potentially replace TCA disulfide quenching as a
viable approach to reducing or eliminating postlysis cysteine oxidation and disulfide
exchange. The benefits of eliminating TCA from the workflow would be elimination of a
precipitation and resuspension step at the start of the procedure, as well as avoiding the
use of a potentially hazardous acid.
This approach has been used in previous studies, although there is a lack of
available data regarding both the efficiency of the pre-lysis blocking, as well as the
optimization of conditions for the blocking step. Therefore we sought to fill in these
blanks to determine whether pre-lysis blocking was a viable alternative to TCA
quenching. We blocked BEAS-2B cells prior to lysis by exchanging their culture
medium with HBSS containing NEM immediately prior to harvesting. Figure 2.2 shows
the results of the blocking experiments.
As can be seen in Fig. 2.2A, significant cysteine blocking was achieved by all
concentrations of NEM trialed. A 15-minute incubation with 1 mM NEM at room
temperature resulted in a decrease in available free thiol of over half, while increasing
NEM concentrations resulted in even further decreases in the free thiol pool. While this
loss of free thiol increased with increasing NEM concentration, the alkylation
demonstrably slowed as the concentration was increased from 25-100 mM; this is most
likely due to the effective alkylation of surface-exposed cysteines, with the remaining
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~25% of free thiols representing conformationally buried cysteines which are
inaccessible to NEM in the proteins’ native configuration.
Given the decreasing cost-benefit ratio of increasing NEM concentration for
prelysis quench, we settled on 50 mM NEM as an optimal concentration of NEM to use
in prelysis quench to both achieve maximal cysteine alkylation while preventing
excessive waste of alkylant. However we wanted to determine whether incubation time
and/or temperature would have a significant effect on prelysis quenching. Therefore we
tested altering the incubation time (Fig. 2.2B), as well as altering the incubation
temperature (Fig. 2.2C), would lead to increased alkylation with a sub-maximal NEM
concentration of 25 mM.
The prelysis quench was essentially finished at 5 minutes, with no substantive
increase in alkylation being gained as the incubation was extended out to 30 minutes. A
slight but non-significant gain in alkylation occurred when the cells were quenched at
37°C instead of RT. Based on these results the optimal prelysis quench conditions were
determined to be incubation with 50 mM NEM for 5 minutes at RT or 37°C, with further
time or concentration increases being unnecessary.
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Figure 2.2. N-ethylmaleimide (NEM) incubation of cell pre-lysis causes significant
cysteine alkylation. 100 μl of the supernatant was pipetted into 3 replicate wells of a 96well plate. To these wells 200 μl of 5,5’-dithio-bis-(2-nitrobenzoic acid) (DTNB) assay
solution (100 mM NaH2PO4 pH 7.8, 1 mM EDTA, 10 mM DTNB) was added. The
plates were briefly shaken to mix and allowed to incubate for 10 minutes in the dark prior
to reading at λ=405 nm. All DTNB measurements were normalized to cell lysate protein
concentrations, determined by BCA assay. (A) BEAS-2B cells were incubated for 15
minutes at RT in the dark with increasing concentrations of NEM. (B) BEAS-2B cells
were incubated with 25 mM NEM at RT in the dark for various incubation times. (C)
BEAS-2B cells were incubated with 25 mM for 5 minutes in the dark at varying
temperatures. HBSS media used was acclimated to the incubation temperature prior to
addition to the BEAS-2B culture dish. Bars and data points represent mean ± SD, n=3.
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Investigation of Alternative Alkylating Reagents
While maleimides are the most commonly-used class of cysteine alkylants in
RAC, they are not without their drawbacks; as Michael acceptors maleimides can
undergo a retro-Michael reaction in the presence of a base. This retro-reaction means
that maleimide-cysteine adducts are reversible in basic media or in the presence of a
competing Michael donor.
Due to this we wanted to investigate alternative cysteine alkylants from
alternative classes of cysteine alkylants reported thus far (reviewed in [69]). This
includes halo-acetamides, alternative Michael donors, electron-deficient alkynes, and
Julia-Kocienski-like reagents. Since the intention of this comparison was to determine
whether NEM was the best-available cysteine alkylant, we limited the compounds
screened to only those compounds which were commercially-available at high purity
(>99%) in reasonable quantity.
We therefore compared the efficacy of NEM to that of the commonly-used haloacetamide iodoacetamide (IAM), the alkenes acrylamide (AAm) [70, 71], butyl acrylate
(BA), methyl acetylacrylate (MAA), ethyl 3-benzoylacrylate [72], ethyl vinyl sulfone
(EVS), and phenyl vinyl sulfone (PVS), the alkynes methyl propiolate (MP) [73, 74],
ethyl propiolate (EP) [74], and 3-phenyl 2-propynenitrile (PPN) [75], the JuliaKocienski-like reagent methyl sulfonylbenzothiazole (MSBT) [76], and finally the selfhydrolyzing maleimide 1-(2-aminoethyl)maleimide (NAEM) [77]. While this list of
reagents is by no means comprehensive, each compound we tested has been shown to
irreversibly alkylate cysteine and has either been proposed or used as an alternative to
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NEM alkylation in prior studies, although the quality of alkylation was variable between
the reagents used.
We expected some alkylating reagents, such as acrylamide, to be poor alkylating
agents in comparison to NEM, since previous studies using acrylamide for cysteine
alkylation prior to proteomic analysis used molar concentrations of acrylamide. However
we were hopeful that some of the more modern reagents, such as MSBT, PPN, and ethyl
3-benzoylacrylate would prove to be effective replacements for NEM. MSBT [76], PPN
[75], and ethyl 3-benzoylacrylate [72] had been shown to be similarly effective as an
equivalent concentration of NEM; Both MSBT and PPN had also been demonstrated to
generate irreversible alkylation products with cysteine, while ethyl 3-benzoylacrylate
alkylated cysteines at a faster rate than NEM but the alkylation product was known to be
unstable and slowly decompose. NEM-cysteine alkylation products likewise have been
demonstrated to decompose due to NEM’s tendency, as with other Michael donors, to
undergo anti-Michael additions at basic pH in the presence of competing thiols to
regenerate free cysteine thiols [78].
This base-catalyzed reversibility of NEM-cysteine alkylation products was
addressed in a prior study by the addition of a basic amino group to maleimide to
generate 1-(2-aminoethyl)maleimide (NAEM) [77]. Maleimides can undergo hydrolysis
at the imine, resulting in succinimide ring opening and resulting in a non-reactive
succinimic acid [79-81]. When this hydrolysis occurs to a maleimide-cysteine alkylation
product, it results in a non-reactive thiosuccinimic acid derivative which cannot undergo
anti-Michael addition. NAEM showed equivalent conjugation rates as NEM, but
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underwent hydrolysis at a much faster rate, resulting in irreversible NAEM-cysteine
alkylation products.
Based off the success of these prior studies in developing alternatives to NEM as
a cysteine alkylating reagent, we wanted to compare the alkylating reagents directly to
determine their relative efficiencies at alkylating a simple monothiol,
mercaptoethylamine, at both neutral and mildly acidic pHs; since N-ethylmaleimide has
been shown to be an effective and specific cysteine alkylating reagent within the pH
range of 6.5-7.5, we examined alkylating reagent efficacies at both pH 6.5 and pH 7.4.
The results of this comparison are shown in Fig. 2.3. With the exception of the
maleimides and methyl acetylacrylate, reaction rates were higher for alkylants at pH 7.4
than at pH 6.5; this is to expected as more thiols would be deprotonated at pH 7.4,
facilitating nucleophilic attack of the electrophilic alkylants. NEM was by far the fastest
thiol alkylant at both pH 7.4 and pH 6.5, with only NAEM and MAA showing similar
reactivity. However MAA-thiol adducts showed significant reversibility as the
incubation timeframe was extended from 10 minutes to overnight (Fig. 2.3B). Only
NEM and the similar maleimide NAEM showed both the rapid reactivity and adduct
stability required for RAC. NAEM is more irreversible than NEM due to its selfhydrolysis to maleimic acid. However NAEM is also far more expensive than NEM and
not available in bulk quantitites. Therefore for routine RAC analysis NEM would
seemingly be the preferable alkylant; however for any experiment which requires longterm processing or storage NAEM could be easily substituted for NEM to avoid any
adduct loss.
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Given the potential risk for NEM-adduct reversibility at basic pH, conducting the
RAC procedure at pH 6.5 instead of pH 7.4 would hopefully eliminate any retro-Michael
reactions. Using this pH for the RAC would have benefits beyond just eliminating NEMadduct reversibility, as previous studies have shown that restricting the reaction pH to
below neutral also reduces non-specific NEM alkylation significantly [82]. By changing
the pH of the alkylation reaction we can therefore both decrease NEM-adduct loss as well
as improve any proteomic results downstream of the RAC technique.

Figure 2.3. Comparison of commercially-available thiol alkylants. (A) 100 μl of 1 mM
alkylant solution in 20 mM NaHPO4 at either pH 6.5 or 7.4 was added to an equal
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volume of 1 mM mercaptoethylamine in triplicate wells of a 96-well plate. The plates
were gently shaken for 10 minutes at RT in the dark. Following incubation 200 μl of
5,5’-dithio-nitro-bis-(2-nitrobenzoic acid) (DTNB) assay solution containing 10 mM
DTNB was added to each well. The plates were mixed, incubated in the dark at RT for
10 minutes, and absorbance was read at λ = 405 nm. (B) Alkylants were incubated with
mercaptoethylamine at pH 7.4 as in Fig. 1.7A, but allowed to incubate either for 10
minutes or overnight prior to DTNB addition. Alkylant abbreviations in the figure are
NEM: N-ethylmaleimide, NAEM: 1-(2-aminoethyl)maleimide, IAM: iodoacetamide,
MSBT: methylsulfonylbenzothiazole, MAA: methyl acetylacrylate, E3BA: ethyl 3benzoylacrylate, AAm: acrylamide, BA: butyl acrylate, EVS: ethyl vinyl sulfone, PVS:
phenyl vinyl sulfone, PPN: 3-phenyl 2-propynenitrile, MP: methyl propiolate, EP:
ethylpropiolate. Bars represent mean ± SD, n=3.

Choice of Denaturant for Alkylation
For PROP, its authors argued that using guanidine hydrochloride as the denaturant
instead of SDS or urea during lysis facilitated more rapid alkylation by NEM. However
guanidine is incompatible with SDS-PAGE and more difficult to remove by organic
precipitation. The use of guanidine would not impact the oxidized cysteine fractions
captured by RAC since the buffer could be easily exchanged on the columns, but it would
impact any loading control used. Since guanidine forms a precipitate with SDS,
precipitation or buffer exchange of the loading fractions would be required prior to
electrophoresis; this would necessarily alter the sample concentration between the
loading control and the actual amount loaded onto the columns, introducing an avoidable
source of sample error. For these reasons it was therefore important to see whether the
increase in alkylation caused by the denaturant choice was significant enough to
necessitate the use of guanidine despite its incompatibility with downstream processes.
The three denaturants guanidine, urea, and sodium dodecyl sulfate (SDS) were
compared to determine whether there was a difference in NEM-cysteine alkylation rates
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caused by the denaturant used. BEAS-2B cells were lysed in lysis buffers that were
identical except for the included denaturant. Denaturant concentrations were chosen
based on literature values, settling on 6 M guanidine hydrochloride, 8 M urea, and 2%
SDS. At these denaturant concentrations protein denaturation should be rapid, exposing
all cysteines and eliminating conformational-dependent alterations in cysteine pKa.
The results of this experiment are summarized in Fig. 2.4A. It is clear that
denaturant choice has a significant effect upon the cysteine alkylation rate, with
guanidine hydrochloride facilitating NEM alkylation far more than either SDS or urea;
the alkylation rates were guanidine> urea > SDS. The effect persisted at slightly acidic
pH (Fig. 2.4B). These results agree with the findings of Templeton et al. that denaturant
choice has an effect on NEM alkylation rate.
However, the above experiment was done in the absence of a prelysis quench
step. Since prelysis quenching would alkylate the majority of protein cysteines, the NEM
added in the lysis buffer would be more effective due to the increased molar ratio
between NEM and the remaining free thiols. Therefore we wanted to see whether
prelysis quenching could raise the effectiveness of SDS-denatured samples to that of
guanidine-denatured samples, thereby permitting the use of the more-compatible
denaturant in lieu of the more-effective one.
As seen in Fig. 2.4C, prelysis quenching of the samples prior to lysis and
alkylation increased the alkylation efficiency of all tested denaturants. This is again most
likely due to the increased molar ratio of NEM:cysteine in the samples since the only
thiols left to alkylate by NEM were those which were conformationally obstructed from

34

prelysis alkylation. This eliminated the difference in effectiveness between guanidine
and SDS, permitting the use of SDS as a lysis buffer for RAC and avoiding any
denaturant interference in either cysteine alkylation rate or downstream analysis by SDSPAGE.
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Figure 2.4. Cysteine alkylation by N-ethylmaleimide (NEM) was measured under
different denaturing lysis conditions. BEAS-2B cells were washed with PBS, detached
from plates, and lysed in degassed lysis buffers (20 mM MOPS, 0.1% NP-40, 150 mM
NaCl, 1 mM EDTA) containing 25 mM NEM and one of three different denaturants (6M
guanidine HCl (GnHCl), 8M urea, or 2% SDS) at (A) pH 7.2 or (B) pH 6.5. The lysates
were incubated for the indicated time points, then 100 μl of each lysate was pipetted into
three replicate wells of a 96-well plate. To these wells 200 μl of 5,5’-dithio-bis-(2nitrobenzoic acid) (DTNB) assay solution (100 mM NaH2PO4 pH 7.8, 1 mM EDTA, 10
mM DTNB) was added. The plates were briefly shaken to mix and allowed to incubate
for 10 minutes in the dark prior to reading at λ=405 nm. (C) BEAS-2B cells were treated
with 50 mM NEM or HBSS vehicle (for zero time point controls) for 15 minutes, washed
with PBS, detached from plates, pelleted, and lysed in g 25 mM NEM and one of three
different denaturants (6M guanidine HCl (GnHCl), 8M urea, or 2% SDS) at pH 6.5 for 5
minutes. All DTNB measurements were normalized to cell lysate protein concentrations,
determined by bicinchoninic acid assay. Bars represent mean relative absorbance ± SD,
n=3.

One- vs. Two-Step Alkylation/Reduction
Having determined that NEM alkylation at pH 6.5 using both prelysis quenching
and SDS denaturation as optimal conditions for a streamlined RAC, we wanted to
compare the one-step PROP method, which features a single precipitation step between
reduction and capture, vs. two-step Ox-RAC method, which features two precipitation
steps between the alkylation-reduction and reduction-capture steps. By eliminating one
of two precipitation steps one-step would significantly shorten processing time for RAC
analysis; however combining NEM quenching and sample reduction into one step risks
potential NEM alkylation of previously-oxidized cysteines if the NEM quenching is not
rapid enough or insufficient.
We therefore compared control and peroxide-treated samples processed using
either one-step alkylation/reduction, where DTT is added directly to the NEM-containing
sample to both quench and reduce, or the two-step which removes the NEM by
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precipitation prior to reduction. As seen in Fig. 2.5 the one-step procedure showed lower
signal fidelity than the two-step procedure with the difference between control and
treated samples being far lower for one-step. This would indicate that one-step
alkylation/reduction results in poor sample quality, likely due to insufficient quenching of
NEM during reduction allowing NEM alkylation of newly-reduced cysteines. However
the decreased workflow required by one-step was a tantalizing goal, and as such we
wanted to determine whether one-step could be modified in such a way as to both
eliminate the need for NEM removal prior to reduction as well as preserve sample
fidelity.

Figure 2.5. Two-precipitation-step resin-assisted capture as exemplified by Ox-RAC
yields higher capture of proteins following peroxide treatment than one-precipitation-step
resin-assisted capture as exemplified by PROP. BEAS-2B cells were treated with PBS or
0.5 mM H2O2 for 1 hr in serum-free DMEM. Following treatment cells were prelysis
quenched with 50 mM N-ethylmaleimide (NEM), pelleted, lysed in PNIES 1.5% lysis
buffer (20 mM NaH2PO4 pH 7.0, 150 mM NaCl, 0.1% Igepal CA-630, 1 mM EDTA,
1.5% SDS), and alkylated with 20 mM NEM as described. Following alkylation 50 mM
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dithiothreitol (DTT) was added directly to the NEM-containing buffer for the samples in
lanes 1-2 (1-step) while the samples in lanes 3-4 (2-step) were precipitated with acetone,
washed 3x with 80% acetone, and resuspended in PNIES lysis buffer containing 50 mM
DTT. Following reduction samples were precipitated with acetone, washed and
processed for resin-assisted capture as described in the Methods. Equivalent amounts of
RAC-processed whole cell lysates as determined by bicinchoninic acid assay were loaded
onto thiopropyl-sepharose columns to capture oxidized proteins, washed, and eluted
(RAC pulldown). The lanes on the left side of the figure were loaded with 5 μg of RACprocessed whole cell lysate (INPUT), and the lanes on the right side of the figure were
loaded with 20 μl of eluate (PULLDOWN) containing only oxidized proteins from each
treatment. NC indicates samples which were alkylated with N-ethylmalemide but not
reduced as a negative control for thiopropyl capture. The gels were visualized after
electrophoresis using Coomassie G-250.

In order for a one-step alkylation/reduction to be feasible, the alkylating reagent
must be completely quenched either before addition of the reductant, or by the reductant
itself. Without total quenching of NEM’s alkylating ability, any newly-reduced thiols
exposed by the reductant will be immediately alkylated, decreasing detection. Therefore
we wanted to determine whether dithiothreitol (DTT), the reductant used in PROP, was
suitable for a one-step procedure. We incubated equimolar concentrations of four
reductants with NEM. The reductants chosen were two monothiols, l-cysteine and 2mercaptoethanol, as well as DTT and dithiobutylamine (DTBA) [83], a dithiol with a
lower pKSH than DTT.
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Figure 2.6. Four thiol-containing compounds were compared for their ability to quench
an equimolar concentration of N-ethylmaleimide (NEM) over time. 50 μl of either lcysteine (2 mM), β-mercaptoethanol (2 mM), dithiothreitol (1 mM), or dithiobutylamine
(1 mM) in 25 mM MOPS, pH 6.5 were added to 50 μl of 2 mM NEM in the same buffer
in triplicate wells of a 96-well plate; for the zero-minute control each thiol compound was
added to 50 μl of buffer alone. After incubation for the indicated amounts of time, 150 μl
of a 5 mM 5,5’-dithio-bis-(2-nitrobenzoic acid) solution (100 mM Tris, pH 8.0) was
added to each well and allowed to incubate with mixing for 5 minutes. Following
incubation the wells were read at 405 nm on a BioTek EL800 spectrophotometer. Bars
represent mean relative absorbance ± SD, n=3.

The results (Fig. 2.6) indicate that both DTT and DTBA were poor NEM
quenchers, leaving 51% and 39%, respectively, of free NEM after a 5-minute incubation.
Based on these results, if the PROP one-step approach is used a significant portion of
NEM would still be available to alkylate the newly-reduced cysteines, reducing signal.
However the two monothiol reductants were far better at quenching NEM, with l-cysteine
leaving only 13% free NEM in solution after 5 minutes. This shows that the idea of
quenching NEM prior to reduction in a one-step approach may be viable using a low-
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pKSH monothiol such as cysteine as a quenching reagent prior to the addition of DTT as a
reductant.
We therefore tested this revised one-step method. In lieu of l-cysteine, which is
relatively difficult to solubilize at neutral pH, we used the simple monothiol
mercaptoethylamine. As seen in Table 1.1 mercaptoethylamine has a pKSH of 8.35,
which is slightly lower than that of l-cysteine; therefore it should have similar quenching
properties as l-cysteine. Additionally mercaptoethylamine is readily soluble in neutral
aqueous solutions and so can easily be prepared immediately prior to use.
Using mercaptoethylamine as an NEM-quenching agent followed immediately by
the addition of DTT as the reducing agent in a one-step approach resulted in a significant
signal improvement over the traditional two-step methodology (Fig. 2.7). Both the onestep and two-step approaches showed an increase in cysteine oxidation with increasing
peroxide concentration, although the increase was more pronounced for the one-step
samples than the two-step. Aside from the increased signal the samples were identical
between one- and two-step; every band that was visible in the two-step sample lanes
corresponded to a band visible in the one-step lanes. The increase in signal fidelity for
the revised one-step is likely due to decreased sample loss and processing time by
eliminating the second precipitation step.
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Figure 2.7. Oxidized cysteine yield by the optimized one-step resin-assisted capture is
higher than with the two-step resin-assisted capture method. Control and 0.1 mM or 0.5
mM hydrogen peroxide-treated BEAS-2B samples were prelysis quenched, pelleted,
lysed, and alkylated with 20 mM N-ethylmaleimide (NEM) as described in the Methods.
Following alkylation 20 mM mercaptoethylamine was added directly to the NEMcontaining buffer and, after a 5 minute incubation, 50 mM dithiothreitol (DTT) was
added for the samples in lanes 9-11 (1-step). The samples in lanes 12-14 (2-step) were
precipitated with acetone, washed 3x, and resuspended in reduction buffer containing 50
mM DTT. Following a one-hour reduction all samples were precipitated with acetone
and processed for resin-assisted capture as described in the Methods. Equivalent
amounts of RAC-processed whole cell lysates as determined by bicinchoninic acid assay
were loaded onto thiopropyl-sepharose columns to capture oxidized proteins, washed,
and eluted (RAC pulldown). The lanes on the left side of the figure were loaded with 5
μg of RAC-processed whole cell lysate (INPUT), and the lanes on the right side of the
figure were loaded with 20 μl of eluate (PULLDOWN) containing only oxidized proteins
from each treatment. NC indicates samples which were alkylated with N-ethylmalemide
but not reduced as a negative control for thiopropyl capture. The gels were visualized
after electrophoresis using Coomassie G-250.
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Conclusions
In comparing the characteristics which differentiated the two resin-assisted
capture techniques, Ox-RAC and PROP, we arrived at an optimized workflow for RAC
which improves upon its predecessors. We determined that TCA quenching, which could
introduce post-lysis oxidative artifacts by trace metals and other oxidants, could be
eliminated by quenching surface-exposed thiols with NEM prior to lysis. The
incorporation of prelysis quenching into the workflow permitted the use of SDS as the
lysis denaturant without a decrease in the alkylation efficiency as compared to GnHCl.
The separation of the alkylant quenching and reduction steps in the one-step PROP
workflow into two distinct steps, with mercaptoethylamine being added as a quenching
agent prior to DTT addition, increased the quality and speed of the RAC procedure
immensely as compared to the conventional two-step RAC method.
These changes to the RAC workflow are inexpensive and easy to incorporate into
existing protocols. The optimized methodology we have developed will save time and
decrease sample error caused by precipitation and handling. This study has indicated that
there are still iterative improvements upon the RAC methodology to be made in order to
develop it into a mature experimental staple. An obvious source for future improvement
and streamlining based on our experience would be the elimination of the final
precipitation step, thereby transforming RAC into a one-day, one-pot technique.
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Chapter 3 : SYNTHESIS AND APPLICATION OF HIGH-CAPACITY THIOL
REDUCTANT-POLYACRYLAMIDE BEADS FOR SOLID-PHASE REDUCTION
OF OXIDIZED CYSTEINES.

Background
The introduction of the two-step quench/reduction into the RAC method was
effective in eliminating the organic precipitation step previously used between alkylation
and reduction. However if the downstream assay is for total cysteine oxidation it was
still necessary to remove the reductant by organic precipitation followed by resuspension
since any excess DTT in the solution would reduce the disulfide bonds formed between
the cysteine thiols and solid-phase resin, thereby preventing capture. We theorized that if
we could remove the reductant without requiring organic precipitation then this could
drastically improve the workflow since as mentioned before each precipitation step incurs
sample loss and increased risk of contamination and user error.
Therefore it was considered highly advantageous to determine some means of
removing reductant without precipitation. Unlike in the case of the alkylant, there was no
easy way to quench or oxidize the reductant without also risking oxidation of the newlyreduced cysteine thiols. DTT’s reducing capacity could be drastically decreased by
decreasing the pH of the sample solution, thereby protonating DTT’s thiols, but those
thiols would still be available for capture by the solid-phase resin – in essence crowding
out the cysteine thiols, preventing sample capture. However if we instead conjugated the
reductant to a neutral resin, thereby making a solid-phase reductant, we could remove the
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reductant from the lysate by a simple centrifugation step in a spin column – in essence an
inversion of the downstream resin-assisted capture.
Solid-phase reductants have been previously applied to the reduction of samples
prior to western blotting and protease digestion. The utility of a solid-phase reductant
was observed as far back as 1973, when Gorecki and Patchornik described the
conjugation of dihydrolipoic acid to polymers [84]. Since that time commerciallyavailable reducing resins have become available. Additionally Grazu et al. [85]
demonstrated that an agarose resin that was highly-substituted with monothiols had act as
a suitable reductant. Therefore the incorporation of a solid-phase reductant into the RAC
workflow was both reasonable and viable in principle.
However the aforementioned solid-phase reductants were designed around
reduction of samples prior to western blotting or protease digestion, and therefore do not
contain the high reductant concentrations made necessary by the inherent limitations of
the optimized RAC method. In order to properly study cysteine oxidation caused by
treatments a quantitative reduction of oxidized cysteines is necessary. During RAC this
is typically achieved by using 50 mM or higher concentrations of DTT; furthermore since
RAC uses a microcentrifuge spin column the upper limit for the sample volume is fixed
at ~600 μl which allows for ~200 μl of resin.
While this is not difficult to achieve using concentrated stock solutions of soluble
DTT, to achieve the same results using an immobilized reductant would require a highlysubstituted resin. As both the sample and reductant resin would compete for the limited
volume of the spin column, having a higher reductant substitution on the resin would
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allow the use of a smaller volume of resin, thereby allowing for a much larger fraction of
the column volume to be occupied by the sample.
As an example, for a 600 μl sample being processed for RAC 30 μmol of DTT are
added to arrive at a final concentration of ~50 mM DTT. Therefore in order to achieve
the same reductant concentration using a solid-phase reductant the resin would need to
have a conjugated reductant amount of 30 μmol/200 μl resin, or 150 μl/ml resin.
Unfortunately commercially-available reducing resins are low-substitution, with a
quantity of reductant available of only 8-25 μmol/ml. In order to utilize a solid-phase
reductant for RAC it was necessary to synthesize a much higher-capacity reducing resin.
Additionally it was hoped that the reducing resin could be synthesized in a manner which
required no specialized equipment or techniques, as well as limiting the use of toxic or
hazardous reagents.
Choice of Solid-Phase Substrate
With these requirements in mind a suitable insoluble substrate was needed to
generate the immobilized reductant. Agarose has been extensively used as an insoluble
support for chemical conjugation [61, 86, 87] due to its low cost and the uncharged
hydrophilic structure of the polysaccharide. Agarose can be relatively easily substituted
with thiols through an epoxidation of the polysaccharide backbone’s hydroxyl groups
using epichlorohydrin, requiring only moderate heating. While Grazu et al. [85] reported
success in generating a high-capacity reducing resin of 1 mmol thiol/g resin (approx. 333
μmol thiol/ml resin with 3 ml/g swell ratio), substitution ranges of 200-250 μmol/ml resin
are more commonly observed [61, 62] using agarose.
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Although less common, polyacrylamide (PAAm) resin has also been used
successfully for small-molecule immobilization to the amide group of the PAAm
backbone. As a solid-phase support PAAm has several advantages over agarose. Both
PAAm and agarose are hydrophilic, but since agarose is derived from polysaccharides it
has much lower chemical stability and durability than the polyethylene-derived PAAm;
PAAm can be easily dried under vacuum for storage without damage, whereas agarose
requires lyophilization with stabilizing additives to prevent structural damage [88].
PAAm can achieve much higher theoretical substitution rates than agarose since the
amide groups in PAAm repeat much more frequently than the hydroxyl groups on the
agarose polysaccharide. Additionally the amide group on PAAm allows for greater
flexibility in its conjugation reactions, since the amide can be derivatized to an amine,
carboxylic acid, or hydrazide [89]. Furthermore the different porosities available for
PAAm resins allow for very narrow fractionation ranges, allowing the complete
exclusion of the sample proteins from the interior of the beads.
PAAm substitution rates of >2 mmol/g have been routinely reported [84, 89].
PAAm resin swell rates depend upon the porosity of the PAAm beads and range from 312 ml/g resin [90]; based on this, it was estimated that the substitution of PAAm resin
would range from ~250-670 μmol/ml resin depending upon the chosen resin porosity. As
this substitution range was comparable to that of agarose, PAAm was chosen as the
immobilization substrate due to its numerous other advantages.
The selection of PAAm allowed for a wide latitude of strategies for thiolation,
given the range of derivatives available. However most of the derivation reactions
required refluxing conditions and toxic chemicals, such as ethylenediamine or hydrazine
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[89]. We therefore sought derivations that could be achieved using relatively mild

conditions and/or reagents more likely to be encountered in a molecular biology lab.
Accordingly we developed a strategy based on conjugation of a dialdehyde to PAAm to
give an activated aldehyde-PAAm, which would allow for further conjugation to a
variety of reducing groups (Fig. 3.1).
Glutaraldehyde-Conjugation of PAAm
Glutaraldehyde will rapidly react with amines and amides over a wide pH range
(≥ pH 3) and will react with thiols in the presence of a primary amine [91]. While
glutaraldehyde has been used to immobilize antigens to PAAm through crosslinking
between the PAAm amide group and amines present on the antigen [92, 93], to date no
one has utilized glutaraldehyde-PAAm reactivity and glutaraldehyde-amine or
glutaraldehyde-thiol reactivity to generate an immobilized solid-phase reductant (Fig.
3.1B.2-3). If possible this synthetic reaction would be highly advantageous since it uses
the aqueous, relatively non-toxic glutaraldehyde as its reactive group instead of the
highly toxic and potentially carcinogenic compounds used in previous syntheses, such as
epichlorohydrin [94-96] and ethylene diamine [97].
We further sought to utilize the versatile nature of PAAm-conjugated
glutaraldehyde to conjugate cysteine reductants which contained neither an amine nor a
thiol. Using acid-catalyzed acetal formation we predicted that we could synthesize highcapacity DTT-PAAm (Fig.3.1B.4) and non-thiol reductant
tris(hydroxylpropyl)phosphine-PAAm (THP-PAAm) resins (Fig. 3.1B.5). The non-thiol
reductant tris(carboxyethyl)phosphine (TCEP) could additionally be conjugated via an
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EDC-mediated amide linkage to amino-PAAm (Fig. 3.1C). This range of synthetic
reactions would allow us to generate a panel of immobilized thiol reductants.
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Figure 3.1. Synthetic routes and structures for polyacrylamide-based reducing resins.
(A) Conjugation reaction between amide group of acrylamide and aldehyde group of
glutaraldehyde. (B) Synthetic routes for aminopropyl-polyacrylamide (1), thiopropyl-
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polyacrylamide (2), mercaptoethylamine-polyacrylamide (3),
tris(hydroxylpropyl)phosphine-polyacrylamide (4), dithiothreitol-polyacrylamide (5).
For all structures “Resin” represents a polyacrylamide backbone. For compounds 1-3 the
reaction conditions were 0.1M NaPO4, pH 7.7, 25°C, 3 hr incubation. For the acetalconjugated compounds 4-5, the reaction conditions were 10 mM HCl, pH 2.2, 25°C, ON.
All reductant compounds were added in molar excess of available aldehyde groups on the
polyacrylamide. The imine formed by the addition of (1) to aldehyde was reduced with
sodium borohydride. Thiol containing compounds (2, 3, 5) were reduced with excess
dithiol or phosphine reductants following conjugation. (C) Synthesis of
tris(carboxylethyl)phosphine-polyacrylamide (TCEP-PAAm) using carbodiimide amide
formation. TCEP and EDC were added in excess to pentaneamine-polyacrylamide. The
reaction conditions were 50 mM MES, pH 4.5, 25°C, 4hr.

Materials and Methods
Materials. The immortalized human bronchial epithelial cell line BEAS-2B was
purchased from American Type Culture Collection (ATCC CRL-9609). Cell culture
medium (Gibco DMEM+GlutaMAX, Gibco 10569), HBSS pH 7.4 (Gibco 14025), PBS
pH 7.4 (Gibco 10010), 5,5’-dithiobis-(2-nitrobenzoic acid) (Thermo Scientific 22582,
Lot# OG189149A), thiopropyl-sepharose 6B resin (GE Healthcare 17042001) and screw
cap microcentrifuge spin columns (Pierce 69705) were purchased from Thermo Fisher
Scientific (Waltham, MA). Bio-Gel P6DG (Bio-Rad 150-0738 Lot# 64053706) was
purchased from Bio-Rad (Hercules, CA). Tris(carboxylethyl)phosphine (TCEP25 Lot#
2801.042518A) was purchased from Gold Biotechnology (St. Louis, MO). Cystamine
dihydrochloride (Aldrich C121509 Lot# BCBQ0040V), tris(hydroxypropyl)phosphine
(Aldrich 777854), trans-4,5-dihydroxy-1,2-dithiane (Aldrich D3511), and
selenocystamine dihydrochloride (Sigma S0520 Lot# SLBS6606) were purchased from
Millipore Sigma (St. Louis, MO). 50% glutaraldehyde solution (VWR 0875 Lot#
0587C463), N-ethylmaleimide (Alfa Aesar 40526, Lot#P290042), dithiothreitol (VWR
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97061), and sodium cyanoborohydride (TCI S0396 Lot# MMQED-MC) was purchased
from VWR (Radnor, PA).
Cell Culture. The immortalized human bronchial epithelial cell line BEAS-2B (ATCC
CRL-9609) was cultured in DMEM with 10% FBS, 1% Pen-Strep at 37°C, 5% CO2 in a
humidified incubator. Cells were subcultured prior to confluence and seeded at 3000
cells/cm2. For experiments the cells were treated at 60-80% confluence, and treated with
the concentrations of metals described in the figures or deionized water as a vehicle
control.
Synthesis of Activated Carbonyl Resins
Activated Carbonyl PAAm Resin. Activated-carbonyl resin was synthesized as described
by Weston and Avrameas [92] with modifications. 1g of polyacrylamide resin (Bio-Gel
P6DG) was rehydrated with deionized water for 4 hours. Following rehydration the resin
was washed with 0.5M sodium phosphate buffer, pH 8. It was then resuspended in 9 ml
of the same buffer, and 6 ml of 50% glutaraldehyde (final 20% v/v) was added to the
resin. The suspension was incubated at 40°C for 4 hours with end-over-end rotation.
Following incubation the resin slurry was transferred to a fritted-glass filter and washed
4x with PBS under vacuum. The resin was allowed to dry until no more water passed
through the filter, then it was resuspended in the specified downstream reaction buffer(s)
and used immediately for downstream syntheses. Alternatively if the resin was to be
stored at this point it was resuspended in PBS containing 10% EtOH and stored at 4°C.
Thiopropyl-PAAm Resin. 1g of activated-carbonyl resin was resuspended in 40 ml of
0.1M sodium phosphate buffer, pH 7.7. 1.58g of sodium thiosulfate was dissolved in 10
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ml of 0.125M Tris-HCl buffer, pH 7.7, and this solution added to this suspension to make
a final concentration of 0.2M sodium thiosulfate, 25 mM Tris-HCl. The suspension was
incubated at 25°C overnight with end-over-end rotation. Following incubation the resin
was washed 4x with diH2O and 4x with ethanol. Following the final wash the resin was
dried overnight under vacuum in a desiccator.
Mercaptoethylamine-PAAm Resin. 1g of activated-carbonyl resin was resuspended in 40
ml of 0.1M sodium phosphate buffer, pH 7.7. 2.85g of cystamine dihydrochloride was
dissolved in 10 ml of diH2O, and this solution added to this suspension to make a final
concentration of 0.25M. An equimolar amount of NaBH3CN was added to the
suspension. The slurry was incubated at 25°C for 3 hours with end-over-end rotation.
Following incubation the resin was washed 4x with 0.1M acetic acid, 4x with deionized
water, and 4x with ethanol. Following the final wash the resin was dried overnight under
vacuum in a desiccator.
Aminopropyl-PAAm Resin. 1g of activated-carbonyl resin was resuspended in 7 ml of
0.1M sodium phosphate buffer, pH 7.7. 1.19g of ammonium bicarbonate was dissolved
in 5 ml of diH2O, and this solution added to this suspension to make a final concentration
of 1M. A molar equivalent of NaBH3CN was added to the solution. The suspension was
incubated at RT for 3 hours with end-over-end rotation. Following incubation the resin
was washed 4x with 0.1M acetic acid, 4x with deionized water, and 4x with ethanol
before drying overnight in a vacuum dessicator.
Tris(carboxylethyl)phosphine-PAAm Resin. 1g of aminopropyl-PAAm was resuspended
in 10 ml of 0.1M MES buffer, pH 4.5. 5 ml of a 0.5M tris(carboxyethyl)phosphine
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(TCEP) stock solution, pH 4.5, was added to bring the final concentration of TCEP to
167 mM. 480 mg of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride
(EDC) was added to the suspension. The suspension was sharply inverted end-over-end
several times to dissolve and mix the EDC thoroughly, then incubated at 25°C for 4 hours
with end-over-end rotation. Following incubation the resin was washed 4x with diH2O
and 4x with ethanol. Following the final wash the resin was dried overnight under
vacuum in a desiccator.
Tris(hydroxylpropyl)phosphine-PAAm Resin. 1g of activated-carbonyl resin was
resuspended in 7 ml of 10 mM HCl, pH 2.2. 1.832 ml Tris(hydroxylpropyl)phosphine
(THPP) was diluted in diH2O, pH-adjusted to pH 2.2 with HCl, and brought to 10 ml to
give a 1M THPP stock solution. 3 ml of this THPP stock solution added to the
suspension to make a THPP quantity of 3 mmol. The slurry was incubated at 25°C
overnight wrapped in foil with end-over-end rotation. Following incubation the resin
was washed 4x with 0.1M acetic acid, 4x with deionized water, and 4x with ethanol.
Following the final wash the resin was dried overnight under vacuum in a desiccator.
Dithiothreitol-PAAm Resin. 1g of activated-carbonyl resin was resuspended in 7 ml of 10
mM HCl, pH 2.2. 456.72 mg of trans-4,5-dihydroxy-1,2-dithiane (3 mmol) was
dissolved in 3 ml of 10 mM HCl, and this solution added to this suspension. The slurry
was incubated at 25°C overnight with end-over-end rotation. Following incubation the
resin was washed 4x with 0.1M acetic acid, 4x with deionized water, and 4x with ethanol.
Following the final wash the resin was dried overnight under vacuum in a desiccator.
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Reduction of thiol-containing resins. 1g of thiol-containing PAAm resin was rehydrated
in 10 ml of PBS. Following rehydration the beads were centrifuged down and the
supernatant removed. PBS was added to bring the total volume to 10 ml, then 5 ml of a
0.5M TCEP, pH 7.0 stock solution was added to bring the final TCEP concentration to
0.15M. The suspension was incubated at 25°C for 1 hour with end-over-end rotation.
Following incubation the resin was washed with diH2O until the flowthrough did not
react with DTNB, indicating complete removal of TCEP (~25x). The resin was then
washed 4x with ethanol and dried overnight under vacuum in a desiccator.
Measurement of PAAm Substitution. Substitution was measured using the DTNB assay
[64] with modifications. 1 mg of resin was placed in a 2 ml microcentrifuge tube. 1 ml

of a 10mM DTNB solution (100 mM sodium phosphate, pH 7.8, 1 mM EDTA) was
added to the tube. The sample was vortexed and incubated with rotation at 25°C for 30
minutes in the dark. Following incubation the resin was pelleted by centrifuging at
16,000x g for 5 minutes. 100 μl of the supernatant was placed into a 96-well plate. The
plate was read at λ=405 nm using a BioTek EL800 spectrophotometer. The absorbance
values for the sample were compared against a mercaptoethylamine standard curve
incubated under identical conditions.
Prelysis Quenching. Following treatment the cell culture medium was exchanged with
HBSS containing NEM (50 mM unless otherwise noted) and incubated briefly. After
incubation the HBSS + NEM was removed, the plates were washed 3x with HBSS, the
cells were detached from the plate with a cell lifter, collected into 1.5ml tubes, pelleted,
and resuspended in degassed lysis buffer.
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Lysate Alkylation and Reduction. BEAS-2B cells were lysed in 400 μl of degassed lysis
buffer containing 20 mM NEM in opaque 2-ml microcentrifuge tubes. The samples were
incubated for 2 hours at RT with gentle end-over-end mixing. 20 mM
mercaptoethylamine was then added to the samples to quench the NEM. After quenching
for 5 minutes 50 mM DTT was added to reduce oxidized cysteines. After a one-hour
incubation the samples were again precipitated with cold acetone, allowed to incubate
overnight at -20°C, and washed 3x with cold 80% acetone before resuspension for RAC.
Resin-Assisted Reduction. Sample pellets were lysed, alkylated, and quenched as
described above. Following quenching the samples were loaded into spin columns
containing 50 mg of buffer-equilibrated solid-phase reductant resin. The columns were
sealed and rotated end-over-end for one hour in the dark at RT. After incubation the
columns were unsealed, placed into clean microcentrifuge tubes, and centrifuged at
16,000xG for 5 minutes to remove the sample from the reductant. Samples were then
loaded into thiopropyl-resin spin columns for RAC.
Resin-Assisted Capture (RAC). Alkylated and reduced sample pellets were resuspended
by pipetting in 400 μl of capture buffer (20 mM CH3COONa pH 4.5, 2% SDS, 1 mM
EDTA). Sample concentration was measured by BCA assay [66], and equal
concentrations of lysates were added to microcentrifuge spin columns containing 35 mg
of buffer-equilibrated thipropyl resin. The columns were sealed and the slurry was
incubated for one hour at RT with rotation. Following incubation the columns were
unsealed, placed into waste collection tubes, and centrifuged at 1,000xG for 1 minute to
remove all nonbound proteins. The columns were washed with 5 column volumes of
capture buffer, 5 column volumes of diH2O, and 1 column volume of Laemmli sample
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buffer. After the final wash 100 μl of Lammli buffer containing 50 mM DTT was added
to the columns, which were sealed and rotated at RT for 30 minutes. The columns were
then unsealed, placed in clean 1.5 ml microcentrifuge tubes, and centrifuged at 1,000xG
to collect the bound fraction.
Gel Electrophoresis and Staining. Equal volumes of sample bound fractions were loaded
in adjacent wells of NuPAGE bis-tris gels. Equal concentrations of input fractions were
loaded to verify equivalent loading of the spin columns between samples. Gels were run
in MOPS SDS-PAGE running buffer at 200V. Following electrophoresis the gels were
removed from the gel cassettes, cut, and placed directly into fixation solution (10% acetic
acid, 50% methanol) and incubated with RT for 15 minutes at RT. The fixation solution
was decanted and replaced with staining solution (0.025% Coomassie G-250, 10% acetic
acid), and the samples were incubated with rocking for 30 minutes at RT. The staining
solution was decanted and the gels were destained with two 30-minute incubations in
10% acetic acid. Following destain the gels were imaged using a ChemiDoc XRS (BioRad, Hercules, CA).

Results and Discussion
Determination of optimum activation pH. While Weston and Avrameas had previously
described experimentally-determined condition optima for PAAm activation, their
experimental conditions and endpoints are significantly far enough away from the current
study that we felt it necessary to re-determine the optimal pH and time for the
glutaraldehyde-PAAm incubation. The previous studies had been focused on protein
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conjugation to polyacrylamide resins and therefore used highly-porous, low-crosslinked
polyacrylamide resins (Bio-Gels P60-P300) to allow large proteins to entire into the bead
macrostructure. For our purposes we wanted to restrict lysate proteins exclusively to the
void volume to prevent protein retention by the resin, which necessitated using highlycrosslinked resins instead. How the difference in macroporosity between our chosen
resin and the resins previously used would affect the ideal activation conditions needed to
be determined.
To find the optimum activation pH, polyacrylamide beads were incubated at 40°C
with glutaraldehyde for 2 hours at various pH values [92] using a pH-adjusted BrittonRobinson universal buffer system. Following this activation the glutaraldehyde-PAAm
beads were incubated with sodium thiosulfate and then reduced to allow quantitation of
thiol substitution of PAAm. Activation levels increased as the pH became slightly
alkaline, with the thiol substitution of the resin being roughly equivalent from pH 8-9
(Fig. 3.2). Activation at pH 10 resulted in the beads forming large aggregates that
required breaking up prior to downstream processing. The samples activated at pH 10
showed far lower thiol substitution than those activated at pH 9. It was also noted that
the samples activated at pH 10 had a significantly smaller sample bead volume and were
a dull yellow color as opposed to the off-white color of both the original resin and all
other pH groups.

57

0.7

SH/g Resin (mmol)

0.6
0.5
0.4
0.3
0.2
0.1
0

6

7

8

9

10

pH

Figure 3.2. Thiol substitution of PAAm beads incubated at different pH. Bio-Gel P6
beads were incubated for two hours at 40 °C in the presence of 20% glutaraldehyde and
0.5M Britton-Robinson buffer at varying pH. After incubation the resin was washed
extensively with PBS, then incubated with 2M Na2S2O3 overnight. Thiolated resins were
reduced with 0.5M tris(carboxylethyl)phosphine, then washed extensively. 1 mg of resin
was added to 1 ml of 5,5’-dithio-bis-(2-nitrobenzoic acid) assay solution, allowed to
equilibrate for 30 minutes, then measured at λ=405 nm to determine thiol content. Bars
represent mean thiol content ± SD, n=3.

Since a large portion of the fractionation characteristics of PAAm resin can be
attributed to their macrostructure, it was important to determine whether the activation
had affected the bead diameter and overall structure. As can be seen in Figure 3.3 the
macroscale structure of the PAAm beads does not change significantly from pH 6-8. At
pH 9 there an increase in bead wall thickness, although the overall diameter of the beads
did not change as compared to non-activated BioGel P6; this increase in thickness is most
likely due to poly-glutaraldehyde formation. As expected the beads incubated at pH 10
had a much smaller diameter than the other groups. Additionally a significant portion of
the beads showed a deformed and “rippled” exterior in sharp contrast to the smooth
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exterior of both the control groups as well as those incubated at other pHs, due most
likely again to poly-glutaraldehyde crosslinking altering the bead structure.

Figure 3.3. Polyacrylamide activation with glutaraldehyde at high pH causes significant
alterations to bead structure. Optical microscopy images of thiolated-polyacrylamide
beads activated at different pH. (A) control Bio-Gel P6. (B) pH 6, (C) pH 7, (D) pH 8,
(E) pH 9, (F) pH 10. Images were captured using a Zeiss AxioObserver A.1 inverted
microscope with an AxioCam MRc 5.

Determination of optimum activation incubation time. To find the optimal incubation
time, PAAm beads were activated at pH 7-9, 40°C for 1-12 hours. Following this
activation the beads were incubated with sodium thiosulfonate, reduced, and quantitated.
For both pH 7 and pH 8 activation levels increased with increasing incubation time in a
roughly linear fashion, with activation rates at each time point being higher for pH 8 than
pH 7. Activation at pH 9 peaked at 1 hour, after which the thiol substitution decreased
rapidly (Fig. 3.4).
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Figure 3.4. Activated aldehyde conjugation to polyacrylamide resin increases with
increasing incubation time. Bio-Gel P6 beads were incubated for the indicated times at
40°C in the presence of 20% glutaraldehyde and 0.5M Britton-Robinson buffer at pH 7,
8, and 9. After incubation the resin was washed extensively with PBS, then incubated
with 2M Na2S2O3 overnight. Thiolated resins were reduced with 0.5M
tris(carboxylethyl)phosphine, then washed extensively. 1 mg of resin was added to 1 ml
of 5,5’-dithio-bis-(2-nitrobenzoic acid) assay solution, allowed to equilibrate for 30
minutes, then measured at λ=405 nm to determine thiol content. Bars represent mean
thiol content ± SD, n=3.

The macroscale structure of the beads was relatively unchanged from the nonactivated control beads for both pH 7 and pH 8 over 1-2 hour activation (Fig. 3.5, B-C
and E-F). As observed in the prior experiment the macroscale structure of the beads
activated at pH 9 changed significantly, with a pronounced thickening of the bead wall in
as little as 1 hour of activation (Fig. 3.5D). This thickening, again due to
polyglutaraldehyde formation, would explain the rapid loss of activation with increased
incubation times – as the activation continued, an increasing amount of free
glutaraldehyde was polymerizing with the bound amide-bound glutaraldehyde and
thickening the bead wall without contributing any further active aldehyde groups to the
resin.
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Figure 3.5. Polyacrylamide activation with glutaraldehyde at for increasing time at pH 89 causes bead diameter decrease and bead wall thickness increase. Optical microscopy
images of thiolated-PAAm beads activated for different times at (B,E) pH 7, (C,F) pH 8,
(D,G) pH 9. (A) control Bio-Gel P6. (B-D) 1-hour incubation. (E-G) 2-hour incubation.
Images were captured using a Zeiss AxioObserver A.1 inverted microscope with an
AxioCam MRc 5.

We observe this bead wall thickening in the pH 8-activated samples as well as the
activation time is increased past 2 hours (Fig. 3.6C,E,G), however the thickening induced
at pH 8 doesn’t appear to coincide with decreased thiolation rates as seen in pH 9activated samples. It is possible that the thickness increase observed in these beads is due
to increased amide-glutaraldehyde loading instead of glutaraldehyde polymerization, or
that the glutaraldehyde polymers formed at pH 8 are structurally distinct from those
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formed at higher pHs and retain more activated aldehydes. The beads incubated at pH 7
showed minimal signs of bead wall thickening even as the activation time increased to 12
hours (Fig. 3.6F).

Figure 3.6. Polyacrylamide activation with glutaraldehyde for 4+ hours at pH 8 but not
pH 7 causes bead diameter decrease and bead wall thickness increase. Optical
microscopy images of thiolated-polyacrylamide beads activated for different times at
(B,D,F) pH 7, (C,E,G) pH 8. (A) control Bio-Gel P6. (B,C) 4-hour incubation. (D,E) 8hour incubation. (F,G) 12-hour incubation. Images were captured using a Zeiss
AxioObserver A.1 inverted microscope with an AxioCam MRc 5.

Weston had described optimal reaction conditions for PAAm activation as
incubating for 17 hours at pH 6.8, 40°C. Based off our own pH and time-course
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experiments it was clear that the previously-described conditions were far from
maximizing glutaraldehyde loading. Due to this discrepancy between the previouslyreported conditions and our own observations we wanted to investigate whether the
activation rate or macroscale changes observed would be altered significantly if the
activation reaction was conducted at room temperature instead of at 40°C (Fig. 3.7). As
can be seen, the activation rate of beads incubated at pH 8 was significantly reduced at
room temperature as compared to 40°C (Fig. 3.7A). However, when we activated beads
at pH 9 at room temperature instead of 40°C the aforementioned decrease in activation
due to polymerization was absent (Fig. 3.7B); with all other conditions equivalent, the
beads activated at pH 9, RT showed an increasing activation level for the entire 6 hourduration of incubation.
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Figure 3.7. Activated aldehyde conjugation to polyacrylamide resin increases with
increasing incubation temperature. Bio-Gel P6 beads were incubated for the indicated
times in the presence of 20% glutaraldehyde and 0.5M Britton-Robinson buffer, at pH 8
(A) or pH 9 (B) at either room temperature or 40°C. After incubation the resin was
washed extensively with PBS, then incubated with 2M Na2S2O3 overnight. Thiolated
resins were reduced with 0.5M tris(carboxylethyl)phosphine, then washed extensively. 1
mg of resin was added to 1 ml of 5,5’-dithio-bis-(2-nitrobenzoic acid) assay solution,
allowed to equilibrate for 30 minutes, then measured at λ=405 nm to determine thiol
content. Bars represent mean thiol content ± SD, n=3.

These results indicated that the activation conditions could be tailored depending
upon the desired endpoint. Within the efficacious pH range (7-9) activation would, in a
time-dependent manner, result in an increase in bead wall thickness. This increase was
both pH-dependent, with thickening occurring faster at more alkaline pH, and timedependent. Additionally carrying out the reaction at elevated temperature resulted in
increased activation for pH 7-8, while it caused very rapid activation and, eventually,
inactivation at pH 9.
These results indicated that the activation conditions which caused the least
alterations to bead macrostructure was determined to be long-duration incubations (12
hours or more) at neutral pH. However for our reductant resins we chose instead to
activate for 4-hours at pH 8/37° C. The reasoning behind this decision was that these
incubation conditions were the best compromise between activation time, glutaraldehyde
loading, and macroscale alterations; the use of these conditions meant that all synthesis
steps for a reducing resin could be conducted in a single workday with the resin ready to
use the following day.
The activated polyacrylamide was used to synthesize a panel of different
reductant resins, the structures of which are reviewed in Fig. 3.1. These resins included
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thiopropyl-polyacrylamide (SH-PAAm), dithiothreitol-polyacrylamide (DTT-PAAm),
tris(hydroxypropyl)phosphine-polyacrylamide (THPP-PAAm),
tris(carboxyethyl)phosphine-polyacrylamide (TCEP-PAAm), and mercaptoethylaminepolyacrylamide (MEA-PAAm). As shown in Table 2.1, the conjugation rate for the
monothiol SH-PAAm was far higher than that of the dithiol DTT-PAAm or either of the
two phosphine-based resins. Some of the discrepancy observed in conjugation rates
between the monothiol and other resins could be due to reaction issues, as both DTT and
THPP conjugation rates were likely lowered in part due to acid-catalyzed acetal
hydrolysis. Additionally the reductant molecules could potentially bind to two aldehydes
(forming hemiacetals for DTT and THPP, and large crosslink structures for TCEP).
Despite this difference in conjugation the reducing ability of the resins would be similar,
as twice the molar concentration of thiol groups would be needed as DTT or phosphine
groups. We therefore expected similar reduction rates between the different resins.
Having developed a panel of different high-capacity reductant resins, we wanted
to test whether the substitution of a solid-phase reductant for DTT in RAC was viable.
The optimized RAC protocol developed previously was used to investigate total
reversible cysteine oxidation in peroxide-exposed BEAS-2B; the protocol was either
carried out as described previously with MEA quenching followed by DTT reduction and
precipitation, or with the MEA-quenched sample loaded into spin columns containing
solid-phase reductant resins. Following reduction the lysate was eluted from the spin
columns with centrifugation and immediately loaded into spin columns containing
thiopropyl capture resin without intermediate precipitation.
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As can be seen in Fig. 3.8, some but not all of the solid-phase reductants were
effective replacements for DTT use in RAC. SH-PAAm showed no significant reduction
of cysteine thiols. DTT-PAAm showed a similar reduction amount as soluble DTT,
while THPP-PAAm caused much higher cysteine reduction that DTT. Interestingly the
other phosphine-based reductant used, TCEP-PAAm, was less effective than either DTT
or THPP-PAAm in reducing cysteines.

Table 3.1. Synthesized Polyacrylamide-Conjugated Reductant Capacities as
Determined by DTNB Assay.
Resin
PAAM-SH
PAAM-DTT
PAAM-THPP
PAAM-TCEP

Conjugated Reductant Amount (mmol/g resin)
1.944 ± 0.034
0.702 ± 0.005
0.634 ± 0.004
0.58 ± 0.004

Figure 3.8. Solid-phase reductants are effective replacements for soluble dithiothreitol in
resin-assisted capture of oxidized cysteines. BEAS-2B lysates treated with vehicle or 0.5
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mM H2O2 were processed via the optimized resin-assisted capture (RAC) protocol as
described in the Methods. Lanes 1-9 were reduced by the corresponding polyacrylamide
reductant resins, while lanes 10-12 were reduced using dithiothreitol in a conventional
optimized RAC using a precipitation step to remove the reductant post-reduction.
Equivalent amounts of reduced whole cell lysates as determined by bicinchoninic acid
assay were loaded onto thiopropyl-sepharose columns to capture oxidized proteins,
washed, and eluted (RAC pulldown). The lanes on the left side of the figure were loaded
with 5 μg of reduced whole cell lysate (INPUT), and the lanes on the right side of the
figure were loaded with 20 μl of eluate (PULLDOWN) containing only oxidized proteins
from each treatment. NC indicates samples which were alkylated with N-ethylmalemide
but not reduced as a negative control for thiopropyl capture. The gels were visualized
after electrophoresis using Coomassie G-250. SH-PAAm: thiopropyl-polyacrylamide.
DTT-PAAm: dithiothreitol-polyacrylamide. THPP-PAAm:
tris(hydroxypropyl)phosphine-polyacrylamide. TCEP-PAAm:
tris(carboxyethyl)phosphine-polyacrylamide.

The difference between the resins were not entirely unexpected, although the
intensity of the differences were interesting. Since the reducing group in SH-PAAm is
mercaptopropylamide, the pKSH of the thiol would be ~ 10.10 (Table 1.1), meaning that it
was predicted to be a poor reductant at the reaction pH of 6.5. However the dramatic
differences between the two phosphines was unexpected although easily explained.
Since TCEP is conjugated to the polyacrylamide via an amide linkage it could be
conjugated with up to three separate acrylamide molecules (Fig. 3.9A-C), thereby
inducing structural impediments to easy cysteine access. Since THPP is instead
conjugated via an acetal (Fig. 3.9D) it would not have the same conformational issues; if
the THPP molecule bound to two or more acrylamides it would form unstable
hemiacetals instead (Fig. 3.9E-F), which would be hydrolyzed in solution.
The increased reactivity of the THPP resin is likely due to its higher efficiency as
a reductant at low pH than DTT [98]. This is most likely the case as the difference in
cysteine oxidation between control and peroxide-treated resins was similar for both DTT-

67

PAAm and THPP-PAAm. However the increased cysteine reduction for THPP-PAAm
may also been caused by phosphine-induced anti-Michael reactions with maleimide, as
trialkylphosphines have been previously shown to act as Michael acceptors and undergo
maleimide conjugation via Michael reaction [99]. Because of this potential side reaction
we sought to develop a thiol-based reductant resin with an efficiency similar to THPPPAAm which would reduce the risk of anti-Michael reactions at acidic pH.

Figure 3.9. Possible conjugation arrangements for phosphine-conjugated polyacrylamide
resins. (A-C) TCEP-acrylamide conjugation arrangements. R1 =
CH2CONHC5H10NHCOCH2-PAAm. (D-F) THPP-acrylamide conjugation
arrangements. R2 = C4H8NHCOCH2-PAAm.
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As discussed previously the highly-substituted monothiol resin SH-PAAm was an
ineffective thiol reducing resin. However previous studies utilizing monothiol-agarose
were able to achieve effective cysteine reduction [85, 100], indicating that a highlysubstituted monothiol-polyacrylamide could be a viable reducing agent. Since thiolbased reductants need to have a high percentage of unprotonated thiolates at a given
reaction pH in order to be effective reductants, we hypothesized that by decreasing the
pKSH of the monothiol-polyacrylamide we might be able to arrive at an effective
monothiol reductant resin for our system.
We therefore took advantage of aldehyde-amine reactivity to generate
mercaptoethylamine-conjugated resins (MEA-PAAm) (Fig. 3.1.3). We compared SHPAAm’s and MEA-PAAm’s effectiveness in reducing oxidized cysteines. In parallel we
added a small molar percentage of selenocysteamine (SeCys) to each reaction to see
whether adding a selenol electron-relay catalyst might improve the reducing efficiencies
of the monothiol resins by permitting easier access to reductant monothiols buried within
the macroporous polyacrylamide resin [101]; as the polyacrylamide resin excludes
molecules larger than 6,000 MW this means that any reductant monothiols in the interior
of the polyacrylamide beads are inaccessible to proteins but not small molecules.
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Figure 3.10. Comparison of SH-PAAm and MEA-PAAm as solid-phase reductants.
BEAS-2B lysates treated with vehicle or 0.5 mM H2O2 were processed using the
modified solid-phase reductant RAC technique previously described. Identical fractions
of the same control and peroxide-treated samples were reduced with either thiopropylpolyacrylamide (SH-PAAm) or mercaptoethylamine-polyacrylamide (MEA-PAAm) with
or without selenocystamine (SeCys) addition. Lanes 1-2 (input) were loaded with 5 μg of
RARC-processed whole-cell lysate from the indicated treatments, reflecting the total
amount of each protein in the lysate. Lane 3 was loaded with 5 μg of whole-cell lysate
which had been blocked with N-ethylmaleimide but not reduced, representing a negative
control for thiopropyl-sepharose capture. Lanes 4-11 (pulldown) are eluate obtained
from loading the SH-PAAm- and MEA-PAAm-reduced whole-cell lysates onto
thiopropyl-sepharose to capture oxidized-cysteine containing proteins, reflecting only the
amount of each protein containing reversibly-oxidized cysteines. NC indicates samples
which were alkylated with N-ethylmalemide but not reduced as a negative control for
thiopropyl capture. After elution from thiopropyl resin the samples were loaded onto
12% Bolt gels, electrophoresed using Bis-Tris, and visualized after electrophoresis using
Coomassie G-250.

As predicted MEA-PAAm was far more effective than SH-PAAm as a reducing
agent in all scenarios tested (Fig. 3.10). Whereas SH-PAAm caused little to no reduction
of oxidized cysteines in our system, MEA-PAAm exhibited reduction capacities similar
to that seen with THPP-PAAm. Interestingly though the addition of SeCys to the system
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decreased the amount of reduced cysteine for MEA-PAAm, although it did preserve the
difference between control and peroxide-treated samples. This could be due to SeCys not
acting as a relay catalyst between monothiol reductants within the interior of the reducing
resin, but instead competing with oxidized protein cysteines for reduction.

Conclusions
The major limitation to a precipitation-free RAC technique is the need to remove
the reductant from the system following cysteine reduction. Any remaining reductant,
whether thiol or phosphine, would interfere with the downstream capture of previouslyoxidized cysteines by thiopropyl-sepharose. This could be avoided by the use of a solidphase reductant instead, as the sample could be separated from the reducing agent by
simply removing the supernatant from the resin through centrifugation. Replacement of
DTT as the reducing agent in the RAC technique with a solid-phase reductant would
simplify and speed up the technique by avoiding time-consuming, user-intensive, and
potential risky reductant removal.
Unfortunately due to the limitations of the RAC technique a viable solid-phase
reductant resin did not previously exist. While there are commercially-available reducing
resins, the capacity of these resins is far lower than what is needed for spin-column
reduction of RAC samples. Highly-substituted monothiol-agarose as a reducing agent
was possible, but the described substitution rates needed for the agarose are difficult to
achieve through the epoxide-based synthesis route.
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We therefore sought to develop polyacrylamide-based reducing resins, since
PAAm provided both the conjugation rate necessary as well as versatility in the
conjugated resin desired through PAAm-glutaraldehyde conjugation. After determining
the optimal reaction conditions for PAAm-glutaraldehyde conjugation, we developed a
range of solid-phase reductant resins based on this activated-aldehyde resin. Several of
these resins worked as well as if not better than DTT when substituted into the RAC
workflow; DTT-PAAm showed cysteine reduction levels similar to soluble DTT, while
both THPP-PAAm and MEA-PAAm showed higher cysteine reduction that DTT.
The use of these resins in a Resin-Assisted Reduction and Capture (RARC)
technique allowed the streamlining of the procedure by avoiding the aforementioned
precipitation steps. Therefore we were able to accomplish the entire RARC processing
from sample lysis through to electrophoresis and staining in a single 8-hour workday.
This is a significant reduction in the processing time needed as compared to the
conventional RAC technique, with no perceivable loss in signal fidelity. Additionally the
synthesis of all required compounds to accomplish RARC can be easily carried out in a
conventional biology lab setting, since the resin uses only commonly-available materials
and equipment. We therefore anticipate that RARC will become a useful technique for
the study of reversible cysteine oxidation in signaling and disease in the future.
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Chapter 4 : APPLICATION OF THE OPTIMIZED RESIN-ASSISTED
REDUCTION AND CAPTURE METHOD FOR THE STUDY OF METALINDUCED CYSTEINE OXIDATION.

Background
Heavy Metal Induced Oxidative Stress
Oxidative stress is a disease state caused an imbalance between reactive oxygen
species (ROS) or reactive nitrogen species (RNS) and antioxidants within the cell. This
can be caused either by an increase in production of ROS and RNS, or by a decrease in
the amount or activity of antioxidant compounds or enzymes. ROS and RNS production
in the cell occurs naturally due to cell processes, such as metabolism, innate immunity,
and cell signaling. In order to prevent these ROS and RNS from damaging the cell,
cellular antioxidants are present to react with and detoxify these reactive species. In the
absence of cellular antioxidants, however, ROS and RNS can react with cellular proteins,
lipids, and nucleotides, inducing oxidative damage. This damage can include lipid
peroxidation, protein oxidation, and DNA oxidative damage and mutation.
The transition metals arsenic, cadmium, and chromium have been shown to
induce cellular oxidative stress. The mechanisms for metal-induced oxidative stress can
be categorized as either redox-active or redox-inactive. Redox-active mechanisms
involve the generation of ROS directly through metal-catalyzed reactions, whereas redoxinactive mechanisms involve the inhibition or inactivation of cellular antioxidants.
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Haber-Weiss-like reactions are two-step reactions which generate hydroxyl
radical from superoxide and hydrogen peroxide. In the first step, a metal Mn is reduced
by superoxide [Eq. 1]. This reduced metal Mn-1 is then oxidized by hydrogen peroxide to
generate a hydroxide ion and hydroxyl radical, as well as regenerating the original metal
valence in a Fenton-like reaction [Eq. 2]. The net reaction from these two steps is the
generation of hydroxide ion and hydroxyl radical from superoxide and hydrogen peroxide
through a catalytic metal redox-shuttling [Eq. 3].
[1]
[2]
[3]

𝑀𝑀𝑛𝑛 + · 𝑂𝑂2− → 𝑀𝑀𝑛𝑛−1 + 𝑂𝑂2

𝑀𝑀𝑛𝑛−1 + 𝐻𝐻2 𝑂𝑂2 → · 𝑂𝑂𝑂𝑂 + 𝑂𝑂𝑂𝑂 −

· 𝑂𝑂2− + 𝐻𝐻2 𝑂𝑂2 → · 𝑂𝑂𝑂𝑂 + 𝑂𝑂𝑂𝑂 − + 𝑂𝑂2

The requirement for a metal to be a Haber-Weiss-like catalyst is the existence of multiple
stable non-zero valence states for that metal. Thus chromium, which has the valence
states (II), (III), (IV), (V), and (VI), is an excellent Haber-Weiss-like catalyst [102].
Additionally arsenic, which has the stable valence states (III) and (V), can also generate
hydroxyl radicals through a Haber-Weiss-like reaction.
In addition to the Haber-Weiss-like reaction, metals which only have one stable
non-zero valence state such as cadmium can generate radicals through a non-Fenton-like
disproportionation reaction [103]. In this multistep reaction an H2O molecule in the
metal-aqua complex is substituted for H2O2 [Eq. 4], the coordinated H2O2 undergoes
protolysis to generate a hydronium ion [Eq. 5], a second H2O2 substitution [Eq. 6], and
peroxide bond cleavage [Eq. 7], followed by rehydration of the complex [Eq. 8-9]. The
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net reaction from these steps is to generate a hydroxyl and peroxyl radical from hydrogen
peroxide [Eq. 10].
−𝐻𝐻2 𝑂𝑂

[4]

[𝑀𝑀(𝐻𝐻2 𝑂𝑂)𝑛𝑛 ]2+ + 𝐻𝐻2 𝑂𝑂2 �⎯⎯� [𝑀𝑀(𝐻𝐻2 𝑂𝑂)𝑛𝑛−1 (𝐻𝐻2 𝑂𝑂2 )]2+

[5]

[𝑀𝑀(𝐻𝐻2 𝑂𝑂)𝑛𝑛−1 (𝐻𝐻2 𝑂𝑂2 )]2+ + 𝐻𝐻2 𝑂𝑂 �⎯⎯⎯� [𝑀𝑀(𝐻𝐻2 𝑂𝑂)𝑛𝑛−1 (𝑂𝑂𝑂𝑂𝑂𝑂)]+

[6]

[𝑀𝑀(𝐻𝐻2 𝑂𝑂)𝑛𝑛−1 (𝑂𝑂𝑂𝑂𝑂𝑂)]+ + 𝐻𝐻2 𝑂𝑂2 �⎯⎯⎯⎯⎯⎯⎯� [𝑀𝑀(𝐻𝐻2 𝑂𝑂)(𝑛𝑛−𝑚𝑚) (𝐻𝐻2 𝑂𝑂2 )(𝑂𝑂𝑂𝑂𝑂𝑂)]+

[7]
[8]
[9]
[10]

−𝐻𝐻3 𝑂𝑂 +

−(𝑚𝑚−1)𝐻𝐻2 𝑂𝑂

[𝑀𝑀(𝐻𝐻2 𝑂𝑂)(𝑛𝑛−𝑚𝑚) (𝐻𝐻2 𝑂𝑂2 )(𝑂𝑂𝑂𝑂𝑂𝑂)]+ → [𝑀𝑀(𝐻𝐻2 𝑂𝑂)(𝑛𝑛−𝑚𝑚) (𝑂𝑂𝑂𝑂)(· 𝑂𝑂𝑂𝑂𝑂𝑂)]+ + · 𝑂𝑂𝑂𝑂
[𝑀𝑀(𝐻𝐻2 𝑂𝑂)(𝑛𝑛−𝑚𝑚) (𝑂𝑂𝑂𝑂)(· 𝑂𝑂𝑂𝑂𝑂𝑂)]+ → [𝑀𝑀(𝐻𝐻2 𝑂𝑂)(𝑛𝑛−𝑚𝑚) (𝑂𝑂𝑂𝑂)]+ + · 𝑂𝑂𝑂𝑂𝑂𝑂
[𝑀𝑀(𝐻𝐻2 𝑂𝑂)(𝑛𝑛−𝑚𝑚) (𝑂𝑂𝑂𝑂)]+ + 𝐻𝐻3 𝑂𝑂+ + (𝑚𝑚 − 2)𝐻𝐻2 𝑂𝑂 → [𝑀𝑀(𝐻𝐻2 𝑂𝑂)𝑛𝑛 ]2+
[𝑀𝑀(𝐻𝐻2 𝑂𝑂)𝑛𝑛 ]2+ + 2𝐻𝐻2 𝑂𝑂2 → [𝑀𝑀(𝐻𝐻2 𝑂𝑂)𝑛𝑛 ]2+ + · 𝑂𝑂𝑂𝑂 + · 𝑂𝑂𝑂𝑂𝑂𝑂

In addition to these redox-active mechanisms, arsenic, cadmium, and chromium
also have redox-inactive mechanisms for inducing oxidative stress. These metals induce
the generation of ROS indirectly by stimulating NADPH oxidase (NOX) activity. NOXs
are a primary source of endogenous ROS; As their name suggests they oxidize NAPDH
to generate superoxide radicals, which undergo dismutation to form hydrogen peroxide.
As(III), Cr(VI), and Cd(II) have all been shown to upregulate both NOX expression and
activity, leading to an increase in NOX-catalyzed ROS production [104-108].
Metal-induced cysteine oxidation can also occur through non-ROS-mediated
pathways. All three metals have also been shown to directly interact with cysteine thiols
through the formation of metal-thiolate complexes. As(III) and Cd(II) have both been
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shown to preferentially displace zinc from zinc-binding motifs such as ZNF domains due
to the increased affinity these metals have for thiolates [109]. Under physiological
conditions Cd(II) interacts with cysteine at a 1:1 or 1:2 Cd(II):Cys molar ratio, although
higher molar ratios have been observed at high cysteine:Cd(II) ratios and alkaline pH
[110-113]. As(III) can bind to cysteine at up to a 1:3 molar ratio, giving a potential range
of thiolate complexes from As(SCys) to As(SCys)3 [114]. Cr(VI) forms Cr(VI)-thioester
groups with cysteine [115] alone or in concert with adjacent carboxylic acids [116].
Additionally trivalent chromium (Cr(III)) generated through chromate reduction in vitro
has been shown to form Cr(III)-Cys-DNA adducts [117-119].
In addition to metal-thiolate complex formation, these heavy metals can also
induce cysteine oxidation directly through metal-cysteine binding. Both arsenic and
cadmium form disulfide bonds between vicinal thiols, which has been used
experimentally to block enzyme active-site cysteines [120, 121].
Metal-Thiol Interactions
Given the significant interaction between As(III), Cr(VI), and Cd(II) and thiols by
both ROS-mediated oxidation and direct metal-thiol binding, it would stand to reason that
cysteine oxidation plays a role in cellular toxicity induced by these metals.
Arsenic
As mentioned previously arsenite binds to vicinal dithiols to form either a thiolate
complex or a disulfide through a redox reaction. Studies using the immobilized arsenitecontaining resin p-aminophenylarsine oxide-sepharose to isolate proteins which bind to
arsenic via metal thiolate formation found that calcineurin (CAN), heat shock protein 27
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(HSP27), galectin-1 (GAL1), triose phosphate isomerase (TPI), thioredoxin (Trx), protein
phosphatase 2A (PP2A), and glutathione s-transferase P1 (GSTP1) all bound to arsenite
[120-123]. Additionally in vitro studies found that arsenic either bound directly to or
oxidized multiple proteins, including metabolic proteins like pyruvate kinase M2
(PKM2), DNA repair proteins like PARP1, heat shock factors like heat shock 70 kDa
protein 9 (HSPA9), and translation machinery including 60S acidic ribosomal protein P0
[124-126].
Chromium
Chromium has been shown to oxidize several antioxidant proteins in vitro. These
include peroxiredoxins (PRXs), thioredoxins (TRXs), and the thioredoxin-reducing
enzyme thioredoxin reductase (TxR) [127-129]. As mentioned previously Cr(VI) has
been shown to generate Cr(VI)-Cys-DNA complexes.
Cadmium
Cadmium has been shown to oxidize TRXs in vitro [130]. Redoxomic studies of
both cytotoxic and noncytotoxic cadmium concentrations using isotope-coded affinity
tagging (ICAT) experiments have shown that cadmium has several protein cysteine
oxidative targets both in vivo and in vitro. These targets include metabolic proteins,
primarily those involved in amino acid and lipid metabolism [131], as well as proteins
involved in translation, stress response, and the actin cytoskeleton [132].
Despite this evidence for cysteine oxidation by As(III), Cr(VI), and Cd(II), to date
no studies have compared the three metals to determine similarities and differences
between their oxidative targets. Given the significant overlap in protein interaction for
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these metals, we would expect that all three metals would share a common pool of
cysteine oxidative targets with some possible variability between them due to differences
in ROS generation and direct thiol conjugation. As such we felt that investigating metalinduced cysteine oxidation in vitro would be an excellent test of the resin-assisted
reduction and capture method’s ability to study complex cysteine oxidants in a cellular
environment.

Materials and Methods
Materials. Cell culture medium (Gibco DMEM+GlutaMAX, Gibco 10569), HBSS pH
7.4 (Gibco 14025), PBS pH 7.4 (Gibco 10010), screw cap microcentrifuge spin columns
(Pierce 69705), and Hypersep C18 micropipettes (Thermo Scientific 60109-209) were
purchased from Thermo Fisher Scientific (Waltham, MA). Trypsin Gold was from
Promega (Madison, WI). Thiopropyl-sepharose 6B, mercaptoethylaminepolyacrylamide, and tris(hydroxypropyl)phosphine-polyacrylamide resins were
synthesized as described previously using sepharose 6B (Aldrich 6B100, Lot#
MKCG3369 ) (Millipore Sigma, St. Louis, MO) and Bio-Gel P6DG (Bio-Rad 150-0738
Lot# 64053706) (Bio-Rad, Hercules, CA). 0.1M sodium arsenite solution (RICCA
714232 Lot# 4603949) and cadmium chloride (Aldrich 202908 Lot# 11026JH) were
purchased from Millipore Sigma (St. Louis, MO). DMPO (5,5-dimethyl-1-pyrroline noxide, TCI D2362 Lot# YPZIA-CG), MTT (VWR 0793 Lot# 0646C193), and Nethylmaleimide (Alfa Aesar 40526 Lot# P290042), and sodium chromate (Alfa Aesar
A10547 Lot# 10161596) were from VWR (Radnor, PA).
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The following antibodies used were from Santa Cruz Biotechnology (Santa Cruz, CA):
mouse anti-eEF2 (C-9), mouse anti-SOD1 (G-11), mouse anti-NNMT (G-4), mouse antivimentin (V-9), and mouse anti-PRDX5 (H-5). The following antibodies used were from
Cell Signaling Technology (Danvers, MA): rabbit anti-GAPDH (D16H11), rabbit antiPKM1/2 (C103A3). Rabbit anti-DJ1/PARK7 (EP2815Y) was from Abcam (Cambridge,
MA). Mouse anti-β-actin (AC-15) was from Millipore Sigma. Anti-mouse and antirabbit near-IR secondary antibodies were from Azure Biosystems (Dublin, CA).
Cell Culture. The immortalized human bronchial epithelial cell line BEAS-2B (ATCC
CRL-9609) was cultured in DMEM with 10% FBS, 1% Pen-Strep at 37°C, 5% CO2 in a
humidified incubator. Cells were subcultured prior to confluence and seeded at 3000
cells/cm2. For experiments the cells were treated at 60-80% confluence, and treated with
the concentrations of metals described in the figures or deionized water as a vehicle
control.
Electron Spin Resonance. BEAS-2B cells were trypsinized, pelleted, washed with
charcoal-stripped PBS twice, and resuspended into 0.5 ml CS-PBS at a concentration of
2x106 cells/ml in a microcentrifuge tube. 200 mM DMPO and treatment metals (or PBS
as vehicle) were added to the cell suspension, which was then sealed and incubated at
37℃ for 10 minutes. Following incubation the cell suspension was transferred to a flat
cell and placed in the chamber of an EMXplus (Bruker, MA). Instrument settings were:
40 mW power, 1G modulation amplitude, 6.32·104 gain, 40.96s conversion time, 9.76
GHz frequency, 100G scan width, 3505G static field, 100 kHz modulation frequency, 42s
scan time, scan number of 9.
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Cell Viability Assay. BEAS-2B cells were trypsinized, counted, and plated into 96-well
plates at 8·103 cells/well in 100 μl cell culture medium and allowed to attach overnight.
The medium was aspirated and replaced with DMEM containing the indicated
concentrations of FBS; DMEM was added to an additional triplicate set of wells without
cells to determine background values. Metals were added to triplicate wells at the
indicated concentrations, with PBS used as the vehicle, for a final well volume of 100 µl.
The plates were incubated at 37°C, 5% CO2 for 24-hours, after which 10 µl of MTT
solution (5 mg/ml in PBS) was added to each well. The plates were incubated for 2
hours, after which 100 µl solubilization solution (40% DMF, 16% SDS, 2% acetic acid)
was added to each well. The plate was mixed by rotational agitation on a plate shaker
until formazan crystals were fully dissolved. Absorbance was measured at 570 nm using
a BioTek EX800 spectrophotometer.
Prelysis Quenching. Following treatment the cell culture medium was exchanged with
HBSS containing NEM (50 mM unless otherwise noted) and incubated briefly. After
incubation the HBSS + NEM was removed, the plates were washed 3x with HBSS, the
cells were detached from the plate with a cell lifter, collected into 1.5ml tubes, pelleted,
and resuspended in degassed lysis buffer.
Lysate Alkylation and Reduction. BEAS-2B cells were lysed in 400 μl of degassed lysis
buffer containing 20 mM NEM in opaque 2-ml microcentrifuge tubes. The samples were
incubated for 2 hours at RT with gentle end-over-end mixing. 20 mM
mercaptoethylamine was then added to the samples to quench the NEM. After quenching
for 5 minutes 50 mM DTT was added to reduce oxidized cysteines. After a one-hour
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incubation the samples were again precipitated with cold acetone, allowed to incubate
overnight at -20°C, and washed 3x with cold 80% acetone before resuspension for RAC.
Resin-Assisted Reduction and Capture (RARC). Sample pellets were lysed, alkylated, and
quenched for 5 minutes with an equimolar amount of mercaptoethylamine (MEA).
Following quenching the samples were loaded into spin columns containing 35 mg of
buffer-equilibrated MEA-PAAm resin. The columns were sealed and rotated end-overend for one hour in the dark at RT. After incubation the columns were unsealed, placed
into clean microcentrifuge tubes, and centrifuged at 13,200xg for 5 minutes to remove the
sample from the reductant. Samples were then loaded into thiopropyl-resin spin columns
for resin-assisted capture.
On-Resin Digestion and Sample Cleanup. Following protein capture onto thiopropylsepharose, columns were unsealed, placed into receiving tubes, and the nonbound fraction
was eluted by centrifugation at 1,500g for 30s and discarded. The columns were then
washed by 3x5 column volumes (CV) of 1% SDS, then 7x5 CV of PBS, 5x5 CV of 30%
acetonitrile (ACN), 0.1% TFA, and 5x5 CV of 30% ACN, 50 mM NaHCO3; the columns
were centrifuged at 1,500g for 30s for each wash and the eluate was discarded. After the
last wash the bottom plugs were replaced and 150 µl of 30% ACN, 50 mM NaHCO3
containing 5 ug of trypsin gold (Promega, Madison, WI) was added to each column. The
columns were sealed and allowed to digest overnight at 37℃ with end-over-end digestion.
After digestion the columns were unsealed, placed into receiving tubes, and nonbound
peptides and trypsin were eluted and discarded. Columns were washed following the above
sequence. Following the last wash 100 µl of elution buffer (25 mM DTT, 50 mM NaHCO3)
was added to each column. The columns were resealed and incubated for 30 minutes at
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RT with rotational agitation, after which the columns were unsealed, placed into methanolcleaned microcentrifuge tubes, and centrifuged to capture the eluate.

This elution

procedure was repeated 3x for a final eluate volume of 400 µl. A sufficient volume of IAM
was added to each eluate tube to bring the final concentration of IAM to 60 mM. The
samples were incubated for 1 hr in the dark at RT to alkylate any free thiols. The eluate
was then evaporated by rotary evaporation on a SpeedVac (Savant/Thermo Fisher
Scientific, Carlsbad, CA) and the peptide pellet was resuspended in 30 ul of 0.5% formic
acid. Peptide samples were cleaned up by Hypersep C18 pipette tips (Thermo Fisher
Scientific, Carlsbad, CA) following manufacturer guidelines. Cleaned-up peptide samples
were again evaporated using rotary evaporation and resuspended in 10 µl of 0.5% formic
acid for LC-ESI-MS/MS injection.
Liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESIMS/MS) Analysis. All mass spectra reported in this study were acquired by the University
of Kentucky Proteomics Core Facility. The tryptic peptides were subjected to shot-gun
proteomics analysis as previously described in Yang et al. [133]. LC-MS/MS analysis was
performed using an LTQ-Orbitrap mass spectrometer (Thermo Fisher Scientific, Waltham,
MA) coupled with an Eksigent Nanoflex cHiPLC™ system (Eksigent , Dublin, CA)
through a nano-electrospray ionization source. The peptide samples were separated with a
reversed phase cHiPLC column (75 μm x 150 mm) at a flow rate of 300 nL/min. Mobile
phase A was water with 0.1% (v/v) formic acid while B was acetonitrile with 0.1% (v/v)
formic acid. A 50 min gradient condition was applied: initial 3% mobile phase B was
increased linearly to 40% in 24 min and further to 85% and 95% for 5 min each before it
was decreased to 3% and re-equilibrated. The mass analysis method consisted of one
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segment with eight scan events. The 1st scan event was an Orbitrap MS scan (300-1800
m/z) with 60,000 resolution for parent ions followed by data dependent MS/MS for
fragmentation of the 7 most intense multiple charged ions with collision induced
dissociation (CID) method.
MS/MS Protein Identification. The LC-MS/MS data were submitted to a local mascot
server for MS/MS protein identification via Proteome Discoverer (version 1.3, Thermo
Fisher Scientific, Waltham, MA) against a custom database of Homo sapiens (Human)
proteins downloaded from Uniprot (number of sequences after taxonomy: 20218). Typical
parameters used in the MASCOT MS/MS ion search were: trypsin digestion with a
maximum

of

two

miscleavages,

cysteine

carbamidomethylation,

cysteine

N-

Ethylmaleimide (NEM) modification, cysteine oxidations, methionine oxidation, 10 ppm
precursor ion and 0.8 Da fragment ion mass tolerances. A decoy database was built and
searched. Filter settings that determine false discovery rates (FDR) are used to distribute
the confidence indicators for the peptide matches. Peptide matches that pass the filter
associated with the FDR rate of 1% and 5% are assigned as high and medium confident
peptides, respectively.
SDS-PAGE.

Following metal treatment cell cultures were processed by RARC as

described above.

Captured samples were eluted in 1x LDS sample buffer (Life

Technologies, CA) + 50 mM TCEP, pH 7.0. Eluted pulldown samples and input fractions
were loaded onto a Bolt Bis-Tris SDS-PAGE gel (Life Technologies, CA) and
electrophoresed in MOPS running buffer at 200V. Once the dye front reached the bottom
of the gel cassette the run was stopped.

83

Western Blotting.

Electrophoresed gels were removed from their gel cassette and

assembled into a transfer sandwich with 0.45 µm nitrocellulose (Bio-Rad, CA). The
transfer sandwiches were rolled out to remove bubbles and loaded into a Hoefer TE-22
tank transfer apparatus (Hoefer) containing Towbin transfer buffer (25 mM Tris, 192 mM
glycine, 10% ethanol). The gels were transferred for 1 hour at 400 mA with regenerative
cooling. Following transfer the membranes were removed and washed briefly with
deionized water, then dried for at least one hour. Membranes were then rehydrated in
deionized water, blocked for 1 hour with 5% milk-PBS, washed 3x with PBS+0.1% NP40 (PBSN), and incubated for 3 hours at RT with primary antibodies in 5% milk-PBSN.
The membranes were then washed 3x with PBSN for 5 minutes each, then incubated for
1hour in the dark at RT with NIR-fluorophore secondary antibodies. The membranes were
washed 3x with PBSN for 5 minutes each, then washed 3x with PBS. Membranes were
imaged at 680 nm and 790 nm using an Azure Biosystems C600 imager. Blot images were
converted from multichannel to grayscale using AzureSpot software.

Results and Discussion
Our lab and others have previously demonstrated ROS generation by As(III),
Cr(VI), and Cd(II) using ESR in both cell-free and in vitro systems. Most EPR
measurements for these metals have been conducted using relatively high concentrations
of metals (0.1-1 mM), which would far exceed the concentration used for biological
studies; these doses would easily overwhelm biological antioxidant systems, and
therefore are not necessarily indicative of the metals’ capacity to generate ROS in a
biologically-relevant system. Therefore we wanted to confirm that measureable ROS
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production was observed under lower, biologically-relevant concentrations of metals used
in 24-hour toxicity studies.
We measured ROS generation in vitro using BEAS-2B cells which had been
treated with As(III), Cr(VI), or Cd(II) using electron spin resonance (ESR) spin trapping.
This method involves the addition-type reaction of a short-lived radical such as hydroxyl
radical with a non-paramagnetic compound (spin trap) to form a relative long-lived
resonance-stabilized paramagnetic product (spin adduct) which can be studied using
ESR. For our analysis we used the spin trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO).
DMPO is a nitrone-containing compound which reacts with hydroxyl radical to form a
resonance-stabilized product DMPO-·OH. While DMPO is non-paramagnetic, DMPO·OH is a paramagnetic compound which is detectable via ESR; therefore measurement of
DMPO-·OH by ESR can be used to measure relative hydroxyl radical levels in the
sample.
We treated BEAS-2B cells with As(III), Cr(VI), and Cd(II) for 10 minutes in the
presence of DMPO, then measured the resulting levels of the DMPO-·OH spin adduct
using ESR. The results of this experiment are in Fig. 4.1. Arsenic did not generate
detectable levels of hydroxyl radical after a 10-minute incubation. Cadmium caused a
small increase in hydroxyl radical as compared to BEAS-2B. Chromium generated
significantly more hydroxyl radical, an approximate doubling of the DMPO-⸱OH signal
as compared to BEAS-2B.
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Figure 4.1. Cr(VI) and Cd(II) generate hydroxyl radicals in BEAS-2B cells as measured
by electron spin resonance (ESR). BEAS-2 cells were trypsinized, counted, and pelleted,
and 1·106 cells were resuspended into 0.5 ml of charcoal-stripped PBS in microcentrifuge
tubes. The indicated concentrations of NaAsO2, K2Cr2O7, and CdCl2 (or PBS as vehicle)
and 200 mM 5,5-dimethyl-1-pyrroline N-oxide (DMPO) spin trap were added to the
BEAS-2B suspensions and incubated for 10 min at 37° C. DMPO reacted with hydroxyl
radicals in the suspension to form the resonance-stabilized paramagnetic product DMPO·OH. The cell suspensions were then transferred to a quartz flat cell and ESR spectra was
measured using a Bruker EMXplus. Instrument settings were: 40 mW power, 1G
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modulation amplitude, 6.32·104 gain, 40.96s conversion time, 9.76 GHz frequency, 100G
scan width, 3505G static field, 100 kHz modulation frequency, 42s scan time, scan
number of 9.

Metal LD50 Determination in FBS-Containing Culture Medium. Most previous studies
have used similar concentrations of both arsenite and chromate in 24-hour acute-toxicity
studies with 20 μM As(III) and 20 μM Cr(VI) being commonly used as the LD50 for these
metals. However the concentrations of cadmium used have varied widely between
different research studies, with anywhere from 10-50 μM Cd(II) being used as an LD50 in
24-hour exposure studies [134, 135]. This discrepancy between reported in vitro LD50
can be partly explained by different studied cell lines and varying media compositions.
As such it was important to reconfirm or determine the dose-dependent response to these
metals in the BEAS-2B immortalized human bronchial epithelial cell line.
Additionally the prior studies had utilized serum-starvation conditions during
metal treatment. Serum-starvation is known to generate oxidative stress [136]. Since
starvation-induced oxidative stress could raise background cysteine oxidation levels, we
wanted to avoid this by treating BEAS-2B cultures under normal culture conditions to
avoid exogenous stressors. As such we conducted a viability assay to determine the 24hour LD50 for As(III), Cr(VI), and Cd(II) under differing medium serum compositions.
The results of this experiment are in Fig. 4.2. Both arsenic and chromium showed
a fairly consistent toxicity profile independent of the presence of serum in the medium,
with As(III) and Cr(VI) LD50s of 25.8 μM and 20 μM respectively. However cadmium
toxicity was highly dependent upon medium serum concentration, with the LD50 for
Cd(II) ranging from ~24.5 μM in serum-free DMEM to 53.9 μM in 10% FBS-DMEM.
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Since cadmium uptake intracellularly has been previously found to be serum-dependent
in in vitro cell cultures [137-139], we would expect some variance in cadmium-induced
cell toxicity due to the presence of serum components since albumins and
metallothioneins contained in FBS may be binding to and preventing Cd(II) uptake by
BEAS-2B cells.
However both 5% FBS and 10% FBS showed similar toxicity profiles indicating
that this difference is not solely due to serum protein binding or chelation of cadmium, as
presumably the increased concentration of serum proteins at 10% FBS would cause a
further decrease in cadmium concentration available for cellular uptake. Since this
inhibitory effect is not solely due to serum protein concentrations, it is most likely due to
a combination of the presence of Cd(II)-binding serum proteins and to serum-induced cell
signaling effects influencing cellular uptake of Cd(II).
Given the 24-hour viability results, we chose to use 5% FBS-DMEM for all
following treatments. This would, as mentioned previously, reduce or eliminate
exogenous stressor-induced oxidative stress. Additionally it would prevent cadmiuminduced toxicity caused by serum-starvation induced cell signaling pathway disruptions.
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Figure 4.2. 24-hour cell viability measurement for dose-course exposures to As(III),
Cr(VI), and Cd(II). BEAS-2B cells in triplicate wells were treated with the indicated
concentrations of NaAsO2 (A), K2Cr2O7 (B), CdCl2 (C) or PBS vehicle with or without
the indicated concentrations of FBS and incubated for 24 hrs. Cell viability following
treatment was determined using the MTT assay as described above. Relative cell
viability was determined by dividing the average OD562 for each treatment concentration
by the OD562 of the corresponding non-treated vehicle controls. Statistical analysis was
performed using Microsoft Excel. Data points represent average relative viability, n=3.
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Measurement of Reversible Cysteine Oxidation Caused by Metal Exposure. Having
determined both the generation of ROS by As(III), Cr(VI), and Cd(II), as well as their
LD50s for BEAS-2B in serum-containing medium, we wanted to determine whether these
metals could induce significant reversible cysteine oxidation in vitro. Furthermore we
wanted to investigate the RARC methodology’s utility in detecting cysteine oxidation
caused by complex oxidants in an experimental setting.
We treated BEAS-2B cultures with metals for 24 hrs and used the RARC method
to measure the resulting levels of reversible cysteine oxidation. The results of this
experiment are in Fig. 4.3. Reversible cysteine oxidation increased in a dose-dependent
manner for all three metals. Since arsenic and cadmium generated lower levels of
hydroxyl radical than chromium in our EPR measurements, we would expect that
cysteine oxidation would be higher for chromium than either of the other two metals were
cysteine oxidation be primarily ROS-driven. However the observed increase was more
pronounced for both arsenic and cadmium than chromium.
Since both arsenic and cadmium can form metal-catalyzed disulfide bridges, this
would be consistent with the observed increases caused by these metals. Therefore the
cysteine oxidation caused by these metals occurs through at least two distinct paths: a
hydroxyl-mediated cysteine oxidation favored by chromium, and a metal-catalyzed
disulfide formation favored by arsenic and cadmium.
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Figure 4.3. The heavy metals As(III), Cr(VI), and Cd(II) induce cysteine oxidation after
24hr treatment. BEAS-2B cultures were treated with sublethal and lethal doses of
NaAsO2 (5 or 20 µM), K2Cr2O7 (2.5 or 10 µM), or CdCl2 (40 or 60 µM) for 24 hrs in 5%
FBS-DMEM at 37 ℃, 5% CO2. Following treatment the cultures were prelysis quenched
and processed for RARC as described in the Methods section. Equivalent amounts of
reduced whole cell lysates as determined by bicinchoninic acid assay were loaded onto
thiopropyl-sepharose columns to capture oxidized proteins, washed, and eluted (RAC
pulldown). The lanes on the left side of the figure were loaded with 5 μg of reduced
whole cell lysate (INPUT), and the lanes on the right side of the figure were loaded with
20 μl of eluate (PULLDOWN) containing only oxidized proteins from each treatment. N
indicates samples which were alkylated with N-ethylmalemide but not reduced as a
negative control for thiopropyl capture. Both input and pulldown fractions were loaded
onto a 12% Bolt bis-tris gel and electrophoresed using MOPS buffer. The gels were
fixed in 10% acetic acid, 50% methanol for 10 minutes, then stained with 0.01%
Coomassie G-250 in 10% acetic acid for 30 minutes. Following extensive destaining
with deionized water, the gels were imaged using an Azure C600.
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Proteomic Analysis of Metal-Induced Reversible Cysteine Oxidation.
While this experiment further reinforced the utility of the RARC method in measuring
cysteine oxidation, it did not elucidate what fraction of observed oxidation was caused by
ROS or metal catalyzed oxidation. Additionally the identity of the proteins oxidized by
these metals was still unknown. Fortunately the RARC method could be adapted to a
proteomic workflow by utilizing on-resin trypsin digestion prior to sample elution and
cleanup from capture resin; proteomic analysis of the resulting cysteine-containing
peptides would tell not only the protein identity, but the exact cysteines oxidized on each
protein.
Quadruplicate sets of metal-treated BEAS-2B lysates were processed via RARC
and digested on-resin, washed, and eluted for cleanup and proteomic analysis using labelfree proteomics. The resulting peptide lists were cleaned up using a peptide ion score
cutoff of ≥ 25. These protein lists were collated across the quadruplicate sets, and only
proteins which were detected in at least three of the four sets were retained. From this
collated set a list of proteins which were present in metal-treated samples but not the
vehicle control samples was generated (Table 3.1), along with the cysteines oxidized on
the proteins by each metal.
Consistent with the results observed in Fig. 4.3, more proteins were oxidized by
arsenic and cadmium than chromium. Two sets of proteins were observed between the
groups: proteins oxidized by all three metals, and proteins oxidized by arsenic, cadmium,
or a combination of these two metals. No proteins were observed to be oxidized by
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chromium but neither of the other two metals consistent with the decreased cysteine
oxidation by Cr(VI) compared to As(III) and Cd(II).
Metabolic, protein synthesis, and antioxidant proteins were significantly enriched
in the metal-oxidized groups. Several of the cysteines identified were known to be ROSsensitive, as with GAPDH, vimentin, and peroxiredoxins, or metal-binding cysteines,
such as metallothionien-2; furthermore several of the identified cysteines are in
enzymatic active sites, which would indicate that these metals may be inhibiting
enzymatic function through cysteine oxidation. These results indicate that cysteine
oxidation may play a role in metal-induced toxicity for As(III), Cr(VI), and Cd(II).
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Table 4.1. List of Reversibly-Oxidized Proteins and Specific Cysteines Oxidized by
As(III), Cr(VI), Cd(II) by Triplicate Inclusion Criteria
Protein Name

GN
Arsenic
C152
C156
C247
C41
C466
C728

Glyceraldehyde-3-Phosphate
Dehydrogenase

GAPDH

Elongation Factor 2

EEF2

Peroxiredoxin-5, Mitochondrial

PRDX5

60S Ribosomal Protein L30

RPL30

Vimentin
Cation-independent mannose-6phosphate receptor

VIM

C52
C92
C328

IGF2R

C134

Peptidyl-prolyl cis-trans
isomerase A

PPIA/CyPA

C161
C62

Heat Shock 70 kDa Protein 6

HSPA6

C624
C605

C204

Heat Shock Protein 105 kDa

HSPH1

ADP-Dependent Glucokinase
60 kDa Heat Shock Protein,
Mitochondrial
Lysosomal Alpha-Mannosidase
Complement Component 1 Q
Subcomponent-Binding Protein,
Mitochondrial
60S Ribosomal Protein L18

ADPGK

C33
C34
C36
C37
C41
C44
C48
C50
C205
C1018
C147
C161
C499
C34
C167
C415

HSPD1

C442

MAN2B1

C472

C1QBP

C186

RPL18

C134
C85
C92

Metallothionein-2

MT2A

Filamin-A

FLNA

Superoxide Dismutase [Cu-Zn]
Cell Surface Glycoprotein
MUC18

SOD1

Protein Disulfide-Isomerase A3

MCAM

PDIA3

Oxidized Cysteines*
Chromium
C152
C156
C247
C41
C466
C728
C204
C100
C52
C328

Cadmium
C152
C156
C247
C466
C728
C204
C100
C52
C92
C328
C134
C161
C62
C115
C308
C605
C624
C33
C34
C36
C37
C41
C44
C48
C50
C2543
C1018
C147
C161

Leucine-Rich RepeatLRRC59
C277
Containing Protein 59
Thioredoxin-Domain Containing
C247
TXNDC5
Protein 5
C121
*Specific Cysteines Identified in Fewer Than 3 Replicate Proteomic Runs are Indicated by Italicized
Font.
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Loosening the inclusion criteria to include all proteins that were identified in duplicate
sets understandably altered the list of proteins oxidized by metals (Table 3.2). While
loosening the criteria would be assumed to just increase the number of proteins identified
across the board, the result was more nuanced. The proteins identified did increase from
21 to 30 in total, but several proteins moved from categories or were omitted under the
revised criteria. PPIA/CyPA and FLNA were reidentified as oxidized by all three metals,
while HSPH1 was oxidized by both As(III) and Cd(II). Several proteins, including
IGF2R, MT2A, SOD1, and ADPGK were excluded from the list of oxidized proteins due
to their identification in two of the four control sets.
For proteins like GAPDH, EEF2, and VIM which were included in the oxidized
set under both criteria, this further reinforced that they should be significantly oxidized
by metals. This is because these proteins showed up in at least 3 of the 4 metal-treated
sets, and yet did not show up in 2 of the control sets. Additionally conditionallyexcluded proteins should not be discounted entirely due to their appearance in the control
sets, since the data suggests that they are more likely to be oxidized due to metal
treatment.
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Table 4.2. List of Reversibly-Oxidized Proteins Identified by Both Triplicate- and
Duplicate-Inclusion Criteria.
Protein Name

GN

Protein Name

Triplicate
Glyceraldehyde-3Phosphate
Dehydrogenase
Elongation Factor 2
Peroxiredoxin-5,
Mitochondrial
60S Ribosomal Protein
L30
Vimentin

Cation-independent
mannose-6-phosphate
receptor
Peptidyl-prolyl cis-trans
isomerase A
Heat Shock 70 kDa
Protein 6
Metallothionein-2
Filamin-A
Superoxide Dismutase
[Cu-Zn]
Cell Surface
Glycoprotein MUC18

Heat Shock Protein 105
kDa
ADP-Dependent
Glucokinase
60 kDa Heat Shock
Protein, Mitochondrial
Lysosomal AlphaMannosidase
Complement
Component 1 Q
Subcomponent-Binding
Protein, Mitochondrial
60S Ribosomal Protein
L18
Protein DisulfideIsomerase A3

GN
Duplicate

Common to All Metals
Glyceraldehyde-3GAPDH
Phosphate
Dehydrogenase
EEF2
Elongation Factor 2
Peroxiredoxin-5,
PRDX5
Mitochondrial
60S Ribosomal Protein
RPL30
L30
VIM
Vimentin
Peptidyl-prolyl cis-trans
isomerase A
Calnexin
Filamin-A
Common to As/Cd

GAPDH
EEF2
PRDX5
RPL30
VIM
PPIA/CyPA
CANX
FLNA

IGF2R
PPIA/CyPA
Heat Shock 70 kDa
Protein 6

HSPA6

HSPA6

MT2A
FLNA
SOD1
MCAM

Cell Surface
Glycoprotein MUC18
Heat Shock Protein 105
kDa
Heat Shock Protein 70
kDa 1A
As Only

MCAM
HSPH1
HSPA1A

HSPH1
ADPGK
60 kDa Heat Shock
Protein, Mitochondrial

HSPD1

HSPD1

MAN2B1

C1QBP
60S Ribosomal Protein
L18
Protein DisulfideIsomerase A3

RPL18
PDIA3
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RPL18
PDIA3

Leucine-Rich RepeatContaining Protein 59

LRRC59

Thioredoxin-Domain
Containing Protein 5

TXNDC5

Leucine-Rich RepeatContaining Protein 59
Cd Only

Putative Heat Shock 70
kDa Protein 7
Torsin-1A-Interacting
Protein 1
Myosin-9
Thrombospondin-1

LRRC59

HSPA7
TOR1AIP1
MYH9
THBS1

We compared the proteomic results for proteins that were identified in both the triplicate
and duplicate analyses to both the UniProt Knowledgebase (UniProtKB) and RedoxDB
databases, as well as the literature, to determine whether the identified cysteines were
known oxidative targets (Table 3.3). We found that many of the cysteines we identified
as being oxidized by metals have been previously reported to be oxidized by ROS,
further validating our results. We additionally identified several cysteines, including
eukaryotic elongation factor 2 (eEF2) C466, 60S ribosomal protein L30 (RPL30) C52
and C92, peptidyl prolyl cis-trans isomerase A (PPIA/CyPA) C161, heat shock 70 kDa
protein 6 (HSPA6) C605 and C624, and leucine-rich repeat-containing protein 59
(LRRC59) C277, which have not been previously identified as reactive.
For the known cysteines, several of them have been shown to be involved in
ROS-mediated cell signaling or oxidative stress. GAPDH C152 is the active-site thiolate,
while mutational studies have shown that C156 facilitates C152 oxidation by ROS
through a proton relay; C156S mutants are significantly more resistant to ROS than
wildtype [140]. Vimentin C328 acts as an oxidant sensor, reorganizing vimentin
cytoskeletal networks in response to oxidative stress [141]. C41 of eukaryotic elongation
factor has been previously shown to be hypersensitive to a variety of oxidants [142-144].
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Table 4.3. List of oxidized cysteines identified by both triplicate- and duplicateinclusion analysis and references for known reactive cysteines.
Protein Name
Glyceraldehyde-3Phosphate
Dehydrogenase
Elongation Factor 2
Peroxiredoxin-5,
Mitochondrial
60S Ribosomal Protein
L30
Vimentin
Peptidyl-prolyl cis-trans
isomerase A
Heat Shock 70 kDa
Protein 6
Cell Surface
Glycoprotein MUC18
60 kDa Heat Shock
Protein, Mitochondrial
60S Ribosomal Protein
L18
Protein DisulfideIsomerase A3
Leucine-Rich RepeatContaining Protein 59

GN

Oxidized Cysteines*

Known Cysteines and References

GAPDH

C152
C156

C152, C156: [140]

EEF2

C41
C466

C41: [142-145]

PRDX5

C204

[146, 147]

VIM

C52
C92
C328

[141]

PPIA/CyPA

C161

HSPA6

C308
C624
C605

C308: [145]

MCAM

C161

UniProt Manual Curation

HSPD1

C442

[148]

RPL18

C134

[145]

PDIA3

C85
C92

[149] (Disulfide)

LRRC59

C277

RPL30

Western Blot Validation of Proteomic Results. We selected several of the proteins
identified to validate the proteomic results (Fig. 3.4A-D). Consistent with the proteomic
results GAPDH, PRDX5, EEF2, and VIM were all increased in metal-treated groups.
PRDX5 oxidation was relatively similar between all three metals (Fig. 3.4A). EEF2 was
more oxidized by As(III) and Cd(II) than Cr(VI) (Fig. 3.4B), while GAPDH was more
oxidized by Cr(VI) than either of the other two metals (Fig. 3.4C). Vimentin was
oxidized at low levels by As(III) and Cr(VI) but was strongly oxidized by Cd(II) (Fig.
3.4D).
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Figure 4.4. Western blot analysis of metal-induced protein cysteine oxidation. BEAS-2B
cells were treated with 20 µM NaAsO2, 10 µM K2Cr2O7, or 60 µM CdCl2 for 24 hrs, then
quenched, captured via RARC, and immunoblotted as described in the methods.
Equivalent amounts of reduced whole cell lysates as determined by bicinchoninic acid
assay were loaded onto thiopropyl-sepharose columns to capture oxidized proteins,
washed, and eluted (RAC pulldown). The lanes on the left side of the figure were loaded
with 5 μg of reduced whole cell lysate (INPUT), and the lanes on the right side of the
figure were loaded with 20 μl of eluate (PULLDOWN) containing only oxidized proteins
from each treatment. N indicates samples which were alkylated with N-ethylmalemide
but not reduced as a negative control for thiopropyl capture. Following SDS-PAGE
electrophoresis the gels were transferred to nitrocellulose, blocked with nonfat milk, and
probed with antibodies. Near-IR secondary antibodies were used for detection on an
Azure C600 using fluorescence. The experiment was done in triplicate.
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In addition to the proteins determined to be consistently oxidized by As(III),
Cr(VI), and Cd(II), we wanted to probe against some other identified targets that were
excluded from the final proteomic results for a variety of reasons. Pyruvate kinase M has
been previously shown to be oxidized by arsenite [124]. PKM was identified by our
proteomic analysis, but it was present in both control and treatment groups. As seen in
Fig. 3.4E, PKM is significantly oxidized by all three metals. Likewise β-actin was
significantly oxidized by all three metals (Fig. 3.4F); in this case β-actin was identified as
being oxidized by the proteomic analysis, but was excluded because the identified
peptide was not unique to an individual actin.
As mentioned previously, SOD1 was identified as being oxidized by As(III) and
Cd(II) using triplicate-inclusion criteria (Table 3.1) but when duplicate-inclusion criteria
was used it was omitted from the list of metal-oxidized proteins(Table 3.2). We therefore
wanted to see whether SOD1 was in fact oxidized by As(III) and Cd(II). SOD1 was
found to be oxidized in both control and treatment groups, with some increase caused by
As(III) (Fig. 3.4H). SOD1 oxidation in the control sample is most likely due to the
presence of intramolecular disulfide bridges; this would explain why SOD1 was excluded
from the proteomic results once the stringency of analysis was loosened.
Additionally DJ-1/PARK7, a known oxidant-response protein, and nicotinamide
n-methyltransferase were identified in a single proteomic run per metal. As seen in Fig.
3.4G and Fig. 3.4I, both proteins were oxidized by As(III), Cr(VI), and Cd(II). Since
proteomic analysis by LC-MS/MS has a higher lower limit for detection than western
blotting, it is understandable that western blotting can detect lower levels of protein
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enrichment than proteomic analysis, at the cost of more time and resources spent probing
against single targets.

Conclusions
As(III), Cr(VI), and Cd(II) are cytotoxic heavy metals which cause oxidative
stress in vitro and in vivo.
We used the resin-assisted reduction and capture (RARC) to determine whether
metals induced whole-proteome cysteine oxidation in vitro, and to identify the proteins
oxidized. We found that arsenic, chromium, and cadmium all induced cysteine oxidation
with arsenic and cadmium increasing cysteine oxidation more than chromium. Label-free
proteomic analysis was used with on-resin digestion to isolate peptides containing
reversibly-oxidized cysteines, allowing us to identify both the proteins and specific
cysteines involved. Proteomic results, confirmed by western blotting, showed that the
metals oxidized oxidoreductase proteins involved in oxidative stress, cellular metabolism,
and protein folding and translation.
These results both confirm that RARC can be used to identify reversibly-oxidized
cysteines as well as directions for further improvements and future research directions. A
label-free proteomic approach was selected for its accessibility, with a simple inclusionexclusion screen used to identify proteins that were oxidized at a high enough level to be
detected reliably in metal-treated samples but not control samples. This approach did not
require comparative analysis of peptide levels between treatment groups, which
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simplified data reduction by naturally excluding samples which were present in both
control and treatment groups at different concentrations.
Unfortunately the relatively high lower limit for LC-MS/MS peptide detection
resulted in several oxidized proteins not being reliably identified via proteomic analysis.
The lack of sample complexity for the proteomic input resulted in single peptides being
identified for several proteins, as would be expected for proteins with a single oxidized
cysteine. For some proteins, such as β-actin, this resulted in the identified peptide being
flagged as non-unique since the sequence was shared between ACTB and ACTG1.
Based on these results, RARC has been demonstrated to be useful technique for
isolating and enriching proteins containing reversibly-oxidized cysteines in a rapid and
reproducible manner. Coupling RARC with western blotting allows for comparative
analysis of protein oxidation caused by treatments for known targets, while coupling
RARC to label-free or labeled proteomic analysis allows for the discovery of new
oxidative targets. Future improvements to the method would include developing a spikein standard methodology that was compatible with RARC and on-resin digestion to
facilitate quantitative proteomics for peptides detected in both control and treatment sets,
and utilizing more sensitive proteomic techniques like MudPIT [150] to decrease the
threshold for proteomic detection of oxidized peptides towards that of western blotting.
Despite this room for improvement, this project has both established the utility of
the RARC method for discovering cysteine modifications and analyzing qualitative
differences in cysteine oxidation between treatments. By utilizing RARC we have been
able to confirm cysteine oxidation on several proteins previously reported to be oxidized
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by As(III) and Cd(II), such as vimentin, β-actin, and pyruvate kinase. Additionally we
have identified several oxidized proteins which were previously not known to be oxidized
by metals, as well as several novel reactive cysteines. While the relative oxidation levels
caused by As(III), Cr(VI), and Cd(II) varied depending on the protein, the overall trend is
that these three metals share similar oxidative targets. These results will allow us to
further understand the role that cysteine oxidation plays in metal-induced oxidative stress
and cytotoxicity.
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Chapter 5 : DISCUSSION
The role of cysteine oxidation in cellular signaling pathways and oxidative stress
is an emerging field of interest in cell biology. Cysteine oxidation as a post-translational
modification is difficult to detect using molecular biology methods, a problem only
exacerbated by the tendency of cysteines to auto-oxidize upon lysis. This hampers
discovery of oxidized cysteines by high-throughput proteomic methods.
Approaches to studying reversibly cysteine oxidation have improved in the past
two decades but are still laborious. The current state of the art for isolating and enriching
proteins containing reversibly-oxidized cysteines, the resin-assisted capture (RAC)
method, still requires several protein precipitation and transfer steps, each of which
increases user handling and risks sample contamination or loss; sample losses due to
precipitation and resuspension could exceed 30% of the original lysate, while either
incomplete drying or overdrying the protein pellet following precipitation could result in
the complete insolubility of the pellet. The losses incurred to these steps are not only
frustrating but also result in a lysate composition at the end of the alkylation and
reduction steps which may no longer resemble the initial starting lysate, muddying the
real-world conclusions which could be drawn from these experiments.
Additionally the complicated nature of this methodology poses a high barrier of
entry for investigators wishing to study reversible cysteine oxidation in cell signaling and
cellular functions. Given the key role that cysteine plays in enzymatic function, oxidative
cell signaling, and stress response it is critical that a reliable, simple method exists for the
study of reversible cysteine oxidation caused by cellular oxidants.
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We sought to improve upon the current RAC methodology with a focus on
eliminating the precipitation steps required, thus both reducing the time required to
isolate reversibly-oxidized fractions for downstream analysis and decreasing loss and
variability between samples. The three precipitation steps were at the initial point of lysis
by trichloroacetic acid-mediated disulfide exchange quenching and precipitation, as well
as two organic solvent precipitation steps between alkylation-reduction and reductioncapture steps using ice-cold acetone.
Trichloroacetic acid-mediated disulfide exchange had been questioned before we
undertook our examination, as prior studies had indicated that it may not be sufficient to
stop cysteine oxidation by the oxidant diamide. Since our lab studies ROS-generating
heavy metals, we were concerned that not only would these metals be insufficiently
quenched by trichloroacetic acid, but more powerful oxidizing species such as chromic
acid could be formed by protonation of the metals at low pH; therefore even trace
amounts of these metals, whether residual amounts left after washing a metal-treated cell
culture or trace contamination of PBS or other wash buffers, could cause artefactual
oxidation of protein cysteines during the disulfide exchange step.
We found that trichloroacetic acid did cause chromate oxidation of protein
cysteines through chromic acid production. However treatment of the cell culture with
the cysteine alkylant N-ethylmaleimide (NEM) prior to lysis and disulfide quenching
significantly reduced cysteine oxidation by chromic acid. Furthermore we found that by
optimizing our NEM pre-lysis alkylation of protein cysteines we could omit the need for
trichloroacetic acid disulfide quenching and replace it with a simple 5 minute pre-lysis
incubation with NEM. This eliminated a time-consuming precipitation step as well as
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any acid-induced post-lysis metal oxidation of protein cysteines, although these benefits
extend beyond just metal contamination. The elimination of free protein cysteine thiols
through NEM alkylation prior to lysis means that post-lysis cysteine oxidation caused by
residual amounts of treatment oxidants would be severely reduced, increasing confidence
that the oxidative modifications detected were caused by specific cysteine oxidation and
not just stochastic lysis- and denaturation-induced oxidation caused by contaminants.
When it came to investigating the organic solvent protein precipitation between
alkylation and reduction, our starting point was a comparison between the standard RAC
method and a variant known as purification of reversibly-oxidized proteins (PROP). The
PROP method had omitted the precipitation step between the alkylation and reduction
phases, instead adding an 2.5-fold molar excess of dithiothreitol (DTT) to the NEMcontaining lysate with the intention that the DTT would be alkylated by any free NEM,
thereby removing inactivating residual NEM, while simultaneously reducing oxidized
cysteines. To our knowledge no studies had compared the standard RAC protocol to the
PROP protocol to see whether the PROP modifications affected the quality of cysteine
reduction and capture.
We found that PROP as originally designed resulted in decreased changes in
protein oxidation detected between control and peroxide-treated BEAS-2B cells when
compared to the conventional RAC method. Dithiol compounds like DTT were found to
be poor NEM quenching reagents, while monothiol compounds like β-mercaptoethanol,
l-cysteine, and mercaptoethylamine were efficient NEM quenching reagents. We
separated NEM-quenching and reduction into two distinct steps, first adding an
equimolar concentration of mercaptoethylamine to our NEM-containing lysates to
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eliminate free NEM prior to the addition of thiol reductant, facilitating cysteine reduction
without fear of NEM alkylating the newly-reduced cysteines.
These simple modifications, NEM pre-lysis treatment and NEM quenching,
allowed us to detect protein oxidation changes induced by hydrogen peroxide at
efficacies rivaling that of RAC-processed samples. Furthermore our optimized RAC
method reduced the time needed to complete the RAC method by a day through the
elimination of two precipitation steps, while it also eliminated post-lysis acid-induced
cysteine oxidation caused by trace metal contaminants through the elimination of
trichloroacetic acid quenching and reduced protein loss and contamination risk by
eliminating an organic solvent precipitation step. These modifications are extremely
simple to incorporate into a RAC workflow, with the only additional reagent needed
being the inexpensive monothiol mercaptoethylamine.
Beyond our analysis of total protein cysteine oxidation, our modified, optimized
method can also be used for the study of specific reversible cysteine oxidants such as
nitrosothiols and sulfenic acids. An RAC workflow for the capture of nitrosothiols or
sulfenic acids relies on alkylation of free cysteine thiols with NEM, followed by
precipitation and resuspension into a buffer containing species specific reductants such as
sinapinic acid for nitrosothiols or sodium arsenite for sulfenic acids. Neither of these
reductants are capable of reducing disulfide bridges, allowing simultaneous reduction and
capture of proteins. The incorporation of an NEM-quenching step would eliminate the
need for precipitation, allowing the lysates to be directly added into a thiopropylsepharose capture column for reduction and capture.
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The elimination of the precipitation step between reduction and capture proved a
greater challenge, since the second precipitation was intended to remove any excess
reductant from the samples prior to cysteine capture. Failure to properly remove the
reductant would decrease or altogether eliminate cysteine capture. In order to address
this we wanted to avoid the need to precipitate samples by incorporating an immobilized
reducing resin; following reduction the samples could be eluted from the immobilized
reductant by centrifugation, allowing the immediate capture of the newly-reduced lysates
without needing a precipitation step.
However commercially-available immobilized reductant resins were
incompatible with our method, being low-capacity and based on highly macroporous
sepharose beads. We addressed this by developing a class of high-capacity reducing
resins based on aldehyde-activation of polyacrylamide desalting resins. We used this
activated aldehyde to generate both solid-phase thiol- and non-thiol reductants and
utilized these reducing resins in place of soluble reductants for the reduction of
reversibly-oxidized cysteines.
This modified RAC technique, resin-assisted reduction and capture (RARC),
achieved cysteine capture fidelity similar to or greater than that of RAC. At the same
time a total RARC workflow, from cell lysis to electrophoresis and transfer, could easily
be performed in a single workday. Additionally because RARC did not require
trichloroacetic acid or organic solvent precipitation, RARC-processed samples did not
have precipitation-induced sample loss or acid-induced artefactual oxidation and greatly
decreased risk of contamination. The use of immobilized reductants which were
effective at acidic pH, such as mercaptoethylamine-polyacrylamide and the phosphine
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reagent tris(hydroxypropyl)phosphine-polyacrylamide, allowed us to conduct the entire
processing at mildly acidic pH. Decreasing pH causes the protonation of protein
thiolates, helping to further reduce disulfide exchange prior to and during NEM
alkylation, as well as preventing anti-Michael addition of alkylated NEM; however since
DTT is only marginally effective below pH 7, prior RAC workflows have been limited to
using alkylation and reduction buffers at neutral or basic pH. The incorporation of our
high-capacity reducing resins eliminates this need to accommodate DTT’s reducing
capacity when selecting buffer pH, resulting in capture efficacies for oxidized cysteines
at pH 6.5 which are higher than a conventional RAC conducted at pH 7.2.
We used RARC to study cysteine oxidation caused by the thiol-reactive and ROSgenerating metals trivalent arsenic (As(III)), hexavalent chromium (Cr(VI)), and divalent
cadmium (Cd(II)). We found that all three metals caused cysteine oxidation. We used
label-free LC-MS/MS proteomic analysis downstream of RARC processing to identify
proteins oxidized by these metals, as well as the specific cysteines oxidized. Proteomic
analysis found that all three metals caused oxidation of several proteins, including the
translation enzyme eukaryotic elongation factor 2, the cytoskeletal protein vimentin, the
antioxidant oxidoreductase peroxiredoxin 5, and the glycolytic enzyme glyceraldehyde 3phosphate dehydrogenase, results which were confirmed by western blot analysis. We
also found that the glycolytic enzyme pyruvate kinase M1/2, the cytoskeletal protein βactin, the redox sensor DJ-1/PARK7, and the xenobiotic metabolism enzyme
nicotinamide N-methyltransferase were oxidized by all three metals.
While these results are interesting in themselves, they also allow us to identify
targets for future research into metal-induced protein oxidation and its inactivation or
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activation of downstream signaling. Having identified oxidized cysteines on these
proteins, we can now use site-directed mutagenesis to determine whether these cysteines
are both necessary for protein function as well as how oxidation of these cysteines
contributes to metal-induced toxicity. We can also use the RARC method to identify and
track time- and dose-dependent changes in metal-induced protein oxidation; label free
proteomic analysis of RARC-processed lysates from different time points and metal
concentrations will allow us to determine differential oxidative products caused by
differing exposures to reactive metals.
This project has demonstrated the utility of RARC. However, as with its
immediate predecessor, RAC, improvements can and should still be made to the RARC
workflow. The stable of immobilized reductants needs to be expanded. For example, the
steric hindrance of the immobilized TCEP-PAAm from being an effective reductant can
be addressed through the use of uronium compounds such as HATU or HBTU for amide
synthesis instead of the carbodiimide EDC. Since TCEP is a commonly-used laboratory
reductant, developing an easily synthesized and effective TCEP-based resin would allow
for easier adoption of the RARC method.
Additional improvements to the solid-phase portions of the technique could
further reduce the time needed to perform RARC by combining the reduction and capture
phases; since both reduction and capture are accomplished via immobilized resins,
physically separating the reducing and capturing components within a single column and
allowing lysate to move freely between them would allow immediate capture of newlyreduced cysteine thiols. This could be accomplished by synthesizing a bimodal resin
which features both reducing and capturing derivitizations physically separated from each
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other, say with the reducing components on the exterior of the resin beads and the
capturing components on the interior. Alternatively a mixed-resin bed combining both
immobilized reductant-polyacrylamide and thiopropyl-sepharose could be examined.
This would further streamline and improve the RARC methodology.
The development of a protocol for spike-in incorporation into cysteine redox
proteomics, whether via RAC and RARC, is also sorely needed. The necessity of using
inclusion/exclusion criteria for our proteomic analysis of metal-induced cysteine
oxidation was caused by not having an effective means for quantitating relative amounts
of the LC-MS/MS-detected proteins between samples. Spike-in standards have been
commonly used for quantitative proteomics before, providing a known amount of a
standard which can be used to quantitate the amounts of protein peptides detected via LCMS/MS. However no studies have addressed the incorporation of spike-in standards for
redox proteomics, specifically the what, when, and where or spiking in. Since cysteine
redox proteomics refines and simplifies the proteome based on cysteine capture and
elution, spiking in a non-cysteine-containing standard at the beginning of an experiment,
or even during capture, would mean that all of that standard would be washed out prior to
elution. However, spiking in a standard following elution and during peptide cleanup
may not provide an accurate relative quantitation of the samples since the spiked standard
has not undergone the some processing steps as the rest of the sample.
Therefore it is critical to address this need, determining what spike-in standards
are useful for RARC-mediated cysteine redox proteomics as well as when and where to
add the standard into the lysates. If properly addressed, label-free cysteine redox
proteomics would be able to reliably determine more subtle changes in cysteine oxidation
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between proteins which were identified in both control and treatment samples, something
which we had to rely upon western blotting to accomplish.
Additionally new and more effective alkylants are always needed within the field.
While we determined that NEM was the most efficient alkylant for our method to date,
NEM is, as mentioned previously, not without its drawbacks. While NEM is highly
specific for cysteine, NEM can still cause trace misalkylation of amino acids other than
cysteine. NEM can also undergo retro-Michael addition, potentially regenerating free
thiols from NEM-alkylated cysteines. While both of these concerns can be and have
been ameliorated by reducing reaction pH to below neutral, these only highlight the need
for better, more specific and irreversible cysteine alkylants in addition to optimized
reaction conditions.
Despite this room for improvement, the RARC technique is a simple and highly
effective modification to the existing RAC methodology. The high-capacity resins
developed can be synthesized inexpensively using common lab equipment, lowering the
barrier to entry for researchers interested in studying cysteine oxidation caused by
cellular oxidants and ROS-generating toxicants. Additionally RARC allows for a singleday experiment to probe for cysteine oxidation, while both capturing more oxidized
proteins and eliminating size exclusion- or precipitation-induced sample loss and
contamination. Since RARC is based on sample separation from an immobilized resin, it
could be easily adapted from our spin-column format to a vacuum manifold system to
speed up washes, or a spin-plate to allow high-throughput processing and potentially
automation of cysteine oxidation analysis.
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Given the increased speed and efficiency of RARC versus the older RAC
technique, we see RARC as a useful new addition to the quiver of available methods to
study reversible cysteine oxidation. RARC can be used to identify cysteine oxidation
caused by oxidants in a rapid, medium-to-high throughput. This will enable the
discovery of new cysteine oxidative targets for oxidants, as well as antioxidant and drug
discovery, allow the routine analysis of cysteine redox signaling pathways during normal
cell function or cell pathology, and enhance our understanding of the role that cysteines
play within the proteome, metabolome, and beyond.
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APPENDICES

Appendix I.
PROTOCOL FOR RESIN-ASSISTED REDUCTION AND CAPTURE (RARC) OF
REVERSIBLY-OXIDIZED PROTEINS
Treatment and Prelysis Quenching of Protein Samples
1. Culture adherent cells to 60-90% confluency in complete culture medium in 10
cm2 cell culture dishes.
2. Remove culture medium and replace with medium containing either vehicle or
treatment compound. Incubate for desired exposure time.
3. Remove the treatment medium, wash once with PBS, then replace the medium
with serum-free medium containing 50 mM NEM. Incubate the cells at 37°C for
15 minutes.
4. Remove quenching medium, then wash the cells carefully with PBS. Aspirate.
Repeat this step once.
5. Detach the cells from the plate using a cell lifter into 1 ml of PBS. Collect the
cells in a 1.5-ml microcentrifuge tube and centrifuge the tube at 200g at 4°C for 5
min. Aspirate the PBS from the cell pellet.
PAUSE/STORAGE: Cell pellets may be stored overnight at -80°C.
Alkylation of Free Thiols
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6. Pipette 600 μl of degassed cell lysis buffer containing 20 mM NEM into each
tube. Incubate the samples in the dark at RT for 2 hours with end-over-end or
rotational mixing.
7. Transfer the samples to TPX tubes for DNA shearing. Working in six-sample
batches, place the samples into the carousel of a precooled BioRuptor Pico
(Diagenode, Denville, NJ). Sonicate for 10 cycles of 30s/30s at 4°C.
NOTE: Samples can be collected, lysed, and alkylated in TPX tubes in order to
avoid sample transfer. If so, handle the tubes carefully since TPX is a brittle
plastic and may be prone to cracking.
NOTE: Alternative DNA shearing techniques may be used. This protocol has
successfully used microtip sonication with no discernable changes in sample
quality. Due to the risks of sample foaming and aspiration using a Bioruptor or
other bath-type sonicator is preferred.
NOTE: SDS in the lysis buffer may precipitate during the shearing incubation. If
this occurs the SDS will redissolve as the samples are brought back to RT.
8. Centrifuge the samples at 16,000g for 5 minutes to pellet cellular debris. Measure
protein concentration using the BCA assay.
Preparation of Reduction and Capture Resins
9. Weigh 35 mg each of MEA-polyacrylamide and thiopropyl Sepharose-6B for
each sample to be enriched. Place the resins in 15-ml tubes.
NOTE: It may be helpful to weigh out an additional sample’s-worth of resins to
avoid running out of rehydrated resin due to pipette retention.
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10. Add deionized water to each tube to rehydrate the resins and incubate for 15
minutes at RT. A good final volume to aim for is 500 μl of water + rehydrated
resin slurry per sample (ex. 5 samples would be 2.5 ml of slurry).
11. Cut the end of a 1-ml pipette tip off at an angle to make a large-bore tip. Use this
large-bore tip to resuspend the resin, and transfer 500 μl of the slurry into spin
column(s).
12. Place the spin column into a 2-ml receiving tube and centrifuge the tube at 1,000g
for 30s at RT. Remove the eluted water from the receiving tube, pipette 500 μl of
water to the resin, and centrifuge. Repeat this wash twice with cell lysis buffer.
13. Place the bottom plug and top cap on the column following the last wash, and
store the tubes at 4°C in the dark until use.
Alkylant Quench and Sample Reduction
14. Add mercaptoethylamine to the samples to a final concentration of 20 mM.
Incubate for 5 minutes with mixing at RT to quench any free NEM.
15. Transfer the samples to the spin columns containing prepared MEA-

polyacrylamide resins, pipetting briefly up and down to break up and mix the
resin into a slurry. After making sure that the bottom plug and top cap are sealed
properly, incubate the samples for 1 hour in the dark at RT with end-over-end
mixing.
16. Remove the bottom plug, loosen the top cap, and place the column into a clean 2-

ml microcentrifuge tube. Centrifuge the columns at 3,000g for 5 min at RT to
elute the reduced lysate.
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Enrichment of Previously-Oxidized Proteins
17. Transfer equal amounts of protein (~350 ug) from each sample into spin columns

containing prepared thiopropyl Sepharose-6B. After sealing both bottom plug
and top cap, incubate the samples for 30 minutes in the dark at RT with rotational
agitation at 800 rpm.
18. Remove the bottom plug, loosen the top cap, and place the column into a 2-ml

microcentrifuge tube. Centrifuge the columns at 1,000g for 30s at RT to remove
all nonbound proteins. Remove the top cap.
19. Wash the resin 3 times with 1% SDS, 7 times with diH2O, 5 times with 30%
acetonitrile/0.1% trifluoroacetic acid, and 5 times with 30% acetonitrile, 50 mM
NaHCO3. Use 5 column volumes (500 μl) for each wash for a total of 100 CVs of
wash. After the last wash replace the bottom plug.
NOTE: If total protein eluate is desired for downstream applications (ex. western
blotting), skip on-resin digestion and proceed to Step 23.
On-Resin Digestion
20. Add 150 μl of digestion buffer (30% acetonitrile, 50 mM NaHCO3) containing 5

μg of MS-grade modified trypsin. Replace the top cap and incubate the columns
overnight at 37 °C with end-over-end mixing.
21. Remove the bottom plug, loosen the top cap, and place the column into a clean
microcentrifuge tube. Centrifuge the columns at 1,000g for 30s at RT to remove
the non-oxidized-cysteine containing fraction.
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NOTE: This fraction can be saved and used for confirmation of the proteomic
results from the oxidized fraction if desired.
22. Remove the top cap and wash the columns 5 times with diH2O, 5 times with 30%
acetonitrile/0.1% TFA, and 5 times with 50 NaHCO3 for a total of 75 CVs. After
the last wash replace the bottom plug.
Elution
23. Add 120 μl of elution buffer (50 mM NaHCO3, 25 mM IAM) to the columns.
Replace the top cap and incubate columns for 30 min at RT with rotational
agitation.
NOTE: If the intended application is western blotting, replace the elution buffer
with 1X Laemmli sample buffer containing 25 mM TCEP.
24. Remove the bottom plug, loosen the top cap, and place the column into a clean
microcentrifuge tube. Centrifuge the columns at 1,000g for 30s at RT to elute the
oxidized-cysteine containing peptides. After centrifugation remove the column
from the receiving tube and replace the bottom plug.
NOTE: If the intended application is western blotting, one round of elution is
enough to elute ~90% of captured proteins. Repeat elutions can be conducted, but
sample concentration will decrease with each repeat. Eluate can be directly used
at this step for SDS-PAGE.
25. Repeat steps 23 and 24 3 times, placing the column into the same microcentrifuge
tube after each incubation. The receiving sample tubes will contain 480 μl of
eluate at this point.
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26. Add 30 μl of 1M iodoacetamide (IAM) to each microcentrifuge tube to bring the
final IAM concentration to ~60 mM. Incubate the tubes for 1 hr at RT in the
dark.
27. Open the tubes and place them in a rotary evaporator. Dry the tubes. Resuspend
the peptide pellets in 30 μl 0.5% formic acid.
28. Clean up the peptide samples with C18 pipette tips. Condition the tips following
manufacturer instructions. Load the samples by 10-50 cycles of sample aspiration
and dispensing. Wash the samples 5 times with 5% acetonitrile, 0.1% formic
disposing of the wash each time. Elute samples with 10 μl 80% acetonitrile, 0.1%
formic acid. Repeat elution step 2 times for a total of 30 μl eluate. Dry down the
cleaned samples using a rotary evaporator and resuspend in 10 μl of 0.1% formic
acid. Samples are now ready for LC-MS/MS analysis.
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